IDEAS home Printed from https://ideas.repec.org/r/oxp/obooks/9780198529453.html
   My bibliography  Save this item

Methods for the Economic Evaluation of Health Care Programmes

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Laurent Molinier & Christel Castelli & Eric Bauvin & Xavier Rebillard & Michel Soulié & Jean-Pierre Daurès & Pascale Grosclaude, 2011. "Cost study of the clinical management of prostate cancer in France: results on the basis of population-based data," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(4), pages 363-371, August.
  2. Djesika D Amendah & George Mukamah & Albert Komba & Carolyne Ndila & Thomas N Williams, 2013. "Routine Paediatric Sickle Cell Disease (SCD) Outpatient Care in a Rural Kenyan Hospital: Utilization and Costs," PLOS ONE, Public Library of Science, vol. 8(4), pages 1-6, April.
  3. Dyfrig Hughes & Joanna Charles & Dalia Dawoud & Rhiannon Tudor Edwards & Emily Holmes & Carys Jones & Paul Parham & Catrin Plumpton & Colin Ridyard & Huw Lloyd-Williams & Eifiona Wood & Seow Tien Yeo, 2016. "Conducting Economic Evaluations Alongside Randomised Trials: Current Methodological Issues and Novel Approaches," PharmacoEconomics, Springer, vol. 34(5), pages 447-461, May.
  4. Joke Bilcke & Philippe Beutels & Marc Brisson & Mark Jit, 2011. "Accounting for Methodological, Structural, and Parameter Uncertainty in Decision-Analytic Models," Medical Decision Making, , vol. 31(4), pages 675-692, July.
  5. Hildegard Seidl & Matthias Hunger & Reiner Leidl & Christa Meisinger & Rupert Wende & Bernhard Kuch & Rolf Holle, 2015. "Cost-effectiveness of nurse-based case management versus usual care for elderly patients with myocardial infarction: results from the KORINNA study," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(6), pages 671-681, July.
  6. Banke-Thomas, Aduragbemi & Nieuwenhuis, Sonja & Ologun, Adesoji & Mortimore, Gordon & Mpakateni, Martin, 2019. "Embedding value-for-money in practice: a case study of a health pooled fund programme implemented in conflict-affected South Sudan," LSE Research Online Documents on Economics 101766, London School of Economics and Political Science, LSE Library.
  7. Zhe Ren & Ingrid Sketris & Kuan Xu, 2012. "Brand-Name and Generic Drug Pricing in a Regulated Environment: Findings from Canada," Working Papers daleconwp2011-04, Dalhousie University, Department of Economics.
  8. Paal Joranger & Arild Nesbakken & Halfdan Sorbye & Geir Hoff & Arne Oshaug & Eline Aas, 2020. "Survival and costs of colorectal cancer treatment and effects of changing treatment strategies: a model approach," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(3), pages 321-334, April.
  9. Mara Airoldi & Alec Morton & Jenifer A. E. Smith & Gwyn Bevan, 2014. "STAR—People-Powered Prioritization," Medical Decision Making, , vol. 34(8), pages 965-975, November.
  10. Refoios Camejo, Rodrigo & McGrath, Clare & Herings, Ron, 2011. "A dynamic perspective on pharmaceutical competition, drug development and cost effectiveness," Health Policy, Elsevier, vol. 100(1), pages 18-24, April.
  11. Saha, Sanjib & Gerdtham, Ulf-G. & Toresson, Håkan & Minthon, Lennart & Jarl, Johan, 2018. "Economic Evaluation of Interventions for Screening of Dementia," Working Papers 2018:20, Lund University, Department of Economics.
  12. Josephine C. Jacobs & Paul G. Barnett, 2017. "Emergent Challenges in Determining Costs for Economic Evaluations," PharmacoEconomics, Springer, vol. 35(2), pages 129-139, February.
  13. Tom L. Drake & Angela Devine & Shunmay Yeung & Nicholas P. J. Day & Lisa J. White & Yoel Lubell, 2016. "Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low‐ and Middle‐Income Countries: A Systematic Literature Review," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 124-139, February.
  14. Mark Oppe & Daniela Ortín-Sulbarán & Carlos Vila Silván & Anabel Estévez-Carrillo & Juan M. Ramos-Goñi, 2021. "Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(5), pages 711-721, July.
  15. Ulla Griffiths & Benedict Anigbogu & Kiran Nanchahal, 2012. "Economic evaluations of adult weight management interventions," Applied Health Economics and Health Policy, Springer, vol. 10(3), pages 145-162, May.
  16. Tazio Vanni & Jonathan Karnon & Jason Madan & Richard White & W. Edmunds & Anna Foss & Rosa Legood, 2011. "Calibrating Models in Economic Evaluation," PharmacoEconomics, Springer, vol. 29(1), pages 35-49, January.
  17. Laurence M. Djatche & Stefan Varga & Robert D. Lieberthal, 2018. "Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events," PharmacoEconomics - Open, Springer, vol. 2(4), pages 371-380, December.
  18. Marian Shanahan & Alison Ritter, 2014. "Cost Benefit Analysis of Two Policy Options for Cannabis: Status Quo and Legalisation," PLOS ONE, Public Library of Science, vol. 9(4), pages 1-12, April.
  19. Listl, Stefan & Chalkley, Martin, 2014. "Provider payment bares teeth: Dentist reimbursement and the use of check-up examinations," Social Science & Medicine, Elsevier, vol. 111(C), pages 110-116.
  20. Afriandi, Irvan & Siregar, Adiatma Y.M. & Meheus, Filip & Hidayat, Teddy & van der Ven, Andre & van Crevel, Reinout & Baltussen, Rob, 2010. "Costs of hospital-based methadone maintenance treatment in HIV/AIDS control among injecting drug users in Indonesia," Health Policy, Elsevier, vol. 95(1), pages 69-73, April.
  21. Saha, Sanjib & Gerdtham, Ulf-G. & Toresson, Håkan & Minthon, Lennart & Jarl, Johan, 2018. "Economic Evaluation of Management of Dementia Patients - A Systematic Literature Review," Working Papers 2018:41, Lund University, Department of Economics.
  22. Valentin Brodszky & Zsuzsanna Beretzky & Petra Baji & Fanni Rencz & Márta Péntek & Alexandru Rotar & Konstantin Tachkov & Susanne Mayer & Judit Simon & Maciej Niewada & Rok Hren & László Gulácsi, 2019. "Cost-of-illness studies in nine Central and Eastern European countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(1), pages 155-172, June.
  23. Wijnen, Wim & Wesemann, Paul & de Blaeij, Arianne, 2009. "Valuation of road safety effects in cost-benefit analysis," Evaluation and Program Planning, Elsevier, vol. 32(4), pages 326-331, November.
  24. Ties Hoomans & Johan Severens & Nicole Roer & Gepke Delwel, 2012. "Methodological Quality of Economic Evaluations of New Pharmaceuticals in the Netherlands," PharmacoEconomics, Springer, vol. 30(3), pages 219-227, March.
  25. Zhang, Wei & Bansback, Nick & Anis, Aslam H., 2011. "Measuring and valuing productivity loss due to poor health: A critical review," Social Science & Medicine, Elsevier, vol. 72(2), pages 185-192, January.
  26. Rosella Levaggi & Michele Moretto & Vincenzo Rebba, 2009. "Investment decisions in hospital technology when physicians are devoted workers," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 18(5), pages 487-512.
  27. Dinesh Khanna & Mansoor Ahmed & Dustin Yontz & Shaari S. Ginsburg & Joel Tsevat, 2008. "Willingness to Pay for a Cure in Patients with Chronic Gout," Medical Decision Making, , vol. 28(4), pages 606-613, July.
  28. Nadja Chernyak & Heribert Sattel & Marsel Scheer & Christina Baechle & Johannes Kruse & Peter Henningsen & Andrea Icks, 2014. "Economic Evaluation of Brief Psychodynamic Interpersonal Therapy in Patients with Multisomatoform Disorder," PLOS ONE, Public Library of Science, vol. 9(1), pages 1-4, January.
  29. Werner Brouwer & Samare Huls & Ayesha Sajjad & Tim Kanters & Leona Hakkaart-van Roijen & Job Exel, 2022. "In Absence of Absenteeism: Some Thoughts on Productivity Costs in Economic Evaluations in a Post-corona Era," PharmacoEconomics, Springer, vol. 40(1), pages 7-11, January.
  30. Craig., Benjamin M. & Busschbach, Jan J.V., 2011. "Revisiting United States valuation of EQ-5D states," Journal of Health Economics, Elsevier, vol. 30(5), pages 1057-1063.
  31. Fabrice Smieliauskas & Chun-Ru Chien & Chan Shen & Daniel Geynisman & Ya-Chen Shih, 2014. "Cost-Effectiveness Analyses of Targeted Oral Anti-Cancer Drugs: A Systematic Review," PharmacoEconomics, Springer, vol. 32(7), pages 651-680, July.
  32. Mark Stabile & Sarah Thomson, 2014. "The Changing Role of Government in Financing Health Care: An International Perspective," Journal of Economic Literature, American Economic Association, vol. 52(2), pages 480-518, June.
  33. Aleksandra Gajic & David Cameron & Jeremiah Hurley, 2010. "The Impact of Alternative Incentives on Response and Retention in a Mixed-Mode Survey," Centre for Health Economics and Policy Analysis Working Paper Series 2010-03, Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada.
  34. Catherine Pitt & Catherine Goodman & Kara Hanson, 2016. "Economic Evaluation in Global Perspective: A Bibliometric Analysis of the Recent Literature," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 9-28, February.
  35. Khan, Md. Tajuddin & Kishore, Avinash & Joshi, Pramod Kumar, 2016. "Gender dimensions on farmers’ preferences for direct-seeded rice with drum seeder in India:," IFPRI discussion papers 1550, International Food Policy Research Institute (IFPRI).
  36. Tina Olsson, 2011. "Comparing top-down and bottom-up costing approaches for economic evaluation within social welfare," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(5), pages 445-453, October.
  37. Wendy Ungar & Katherine Boydell & Sharon Dell & Brian Feldman & Deborah Marshall & Andrew Willan & James Wright, 2012. "A Parent-Child Dyad Approach to the Assessment of Health Status and Health-Related Quality of Life in Children with Asthma," PharmacoEconomics, Springer, vol. 30(8), pages 697-712, August.
  38. Marie-Odile Carrère & Nathalie Havet & Magali Morelle & Raphaël Remonnay, 2008. "Analyzing the determinants of willingness-to-pay values for testing the validity of the contingent valuation method. Application to home care compared to hospital care," Post-Print halshs-00303725, HAL.
  39. Noémi Kreif & Richard Grieve & M. Zia Sadique, 2013. "Statistical Methods For Cost‐Effectiveness Analyses That Use Observational Data: A Critical Appraisal Tool And Review Of Current Practice," Health Economics, John Wiley & Sons, Ltd., vol. 22(4), pages 486-500, April.
  40. John Brazier & Christopher McCabe, 2007. "‘Is there a case for using visual analogue scale valuations in CUA’ by Parkin and Devlin a response: ‘yes there is a case, but what does it add to ordinal data?’," Health Economics, John Wiley & Sons, Ltd., vol. 16(6), pages 645-647, June.
  41. Ângela J. Ben & Jeruza L. Neyeloff & Camila F. Souza & Ana Paula O. Rosses & Aline L. Araujo & Adriana Szortika & Franciele Locatelli & Gabriela Carvalho & Cristina R. Neumann, 2020. "Cost-utility Analysis of Opportunistic and Systematic Diabetic Retinopathy Screening Strategies from the Perspective of the Brazilian Public Healthcare System," Applied Health Economics and Health Policy, Springer, vol. 18(1), pages 57-68, February.
  42. Kees van Gool & Marion Haas & Gisselle Gallego & Kathy Tannous & Ilan Katz, 2009. "Framework for the cost benefit analysis of the NSW Department of Community Services Brighter Futures Program. CHERE Working Paper 2009/4," Working Papers 2009/4, CHERE, University of Technology, Sydney.
  43. C Simone Sutherland & Joshua Yukich & Ron Goeree & Fabrizio Tediosi, 2015. "A Literature Review of Economic Evaluations for a Neglected Tropical Disease: Human African Trypanosomiasis (“Sleeping Sickness”)," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 9(2), pages 1-22, February.
  44. Barbara Graaff & Lei Si & Amanda L. Neil & Kwang Chien Yee & Kristy Sanderson & Lyle C. Gurrin & Andrew J. Palmer, 2017. "Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model," PharmacoEconomics - Open, Springer, vol. 1(1), pages 37-51, March.
  45. Gregory Merlo & Katie Page & Julie Ratcliffe & Kate Halton & Nicholas Graves, 2015. "Bridging the Gap: Exploring the Barriers to Using Economic Evidence in Healthcare Decision Making and Strategies for Improving Uptake," Applied Health Economics and Health Policy, Springer, vol. 13(3), pages 303-309, June.
  46. Boone, Jan, 2015. "Basic versus supplementary health insurance: Moral hazard and adverse selection," Journal of Public Economics, Elsevier, vol. 128(C), pages 50-58.
  47. Arturo J Rios-Diaz & Jimmy Lam & Margarita S Ramos & Andrea V Moscoso & Patrick Vaughn & Cheryl K Zogg & Edward J Caterson, 2016. "Global Patterns of QALY and DALY Use in Surgical Cost-Utility Analyses: A Systematic Review," PLOS ONE, Public Library of Science, vol. 11(2), pages 1-13, February.
  48. Thomas Grochtdreis & Judith Dams & Hans-Helmut König & Alexander Konnopka, 2019. "Health-related quality of life measured with the EQ-5D-5L: estimation of normative index values based on a representative German population sample and value set," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(6), pages 933-944, August.
  49. Christopher Fitzpatrick & Katherine Floyd, 2012. "A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis," PharmacoEconomics, Springer, vol. 30(1), pages 63-80, January.
  50. Cole, Donald C. & Levin, Carol & Loechl, Cornelia & Thiele, Graham & Grant, Frederick & Girard, Aimee Webb & Sindi, Kirimi & Low, Jan, 2016. "Planning an integrated agriculture and health program and designing its evaluation: Experience from Western Kenya," Evaluation and Program Planning, Elsevier, vol. 56(C), pages 11-22.
  51. Pauline Ford & Anton Clifford & Kim Gussy & Coral Gartner, 2013. "A Systematic Review of Peer-Support Programs for Smoking Cessation in Disadvantaged Groups," IJERPH, MDPI, vol. 10(11), pages 1-16, October.
  52. Wei Zhang & Huiying Sun & Simon Woodcock & Aslam H. Anis, 2017. "Valuing productivity loss due to absenteeism: firm-level evidence from a Canadian linked employer-employee survey," Health Economics Review, Springer, vol. 7(1), pages 1-14, December.
  53. Boone, Jan, 2013. "Does the market choose optimal health insurance coverage?," CEPR Discussion Papers 9420, C.E.P.R. Discussion Papers.
  54. Kinchin, Irina & Doran, Christopher M. & McCalman, Janya & Jacups, Susan & Tsey, Komla & Lines, Katrina & Smith, Kieran & Searles, Andrew, 2017. "Delivering an empowerment intervention to a remote Indigenous child safety workforce: Its economic cost from an agency perspective," Evaluation and Program Planning, Elsevier, vol. 64(C), pages 85-89.
  55. R. Hoorn & A. Donders & M. Oppe & P. Stalmeier, 2014. "The Better than Dead Method: Feasibility and Interpretation of a Valuation Study," PharmacoEconomics, Springer, vol. 32(8), pages 789-799, August.
  56. Brian W. Weir & Jennifer Cantrell & David R. Holtgrave & Marisa S. Greenberg & Ryan D. Kennedy & Jessica M. Rath & Elizabeth C. Hair & Donna Vallone, 2018. "Cost and Threshold Analysis of the FinishIt Campaign to Prevent Youth Smoking in the United States," IJERPH, MDPI, vol. 15(8), pages 1-7, August.
  57. Hareth Al-Janabi & Terry N. Flynn & Joanna Coast, 2011. "Estimation of a Preference-Based Carer Experience Scale," Medical Decision Making, , vol. 31(3), pages 458-468, May.
  58. Lairson, David R. & Chung, Tong Han & Smith, Lisa G. & Springston, Jeffrey K. & Champion, Victoria L., 2015. "Estimating development cost of an interactive website based cancer screening promotion program," Evaluation and Program Planning, Elsevier, vol. 50(C), pages 56-62.
  59. Irma H J Everink & Jolanda C M van Haastregt & Silvia M A A Evers & Gertrudis I J M Kempen & Jos M G A Schols, 2018. "An economic evaluation of an integrated care pathway in geriatric rehabilitation for older patients with complex health problems," PLOS ONE, Public Library of Science, vol. 13(2), pages 1-21, February.
  60. Jason S Haukoos & Jonathan D Campbell & Amy A Conroy & Emily Hopkins & Meggan M Bucossi & Comilla Sasson & Alia A Al-Tayyib & Mark W Thrun & For the Denver ED HIV Opt-Out Study Group, 2013. "Programmatic Cost Evaluation of Nontargeted Opt-Out Rapid HIV Screening in the Emergency Department," PLOS ONE, Public Library of Science, vol. 8(12), pages 1-6, December.
  61. McLaren, Zoë M. & Sharp, Alana & Hessburg, John P. & Sarvestani, Amir Sabet & Parker, Ethan & Akazili, James & Johnson, Timothy R.B. & Sienko, Kathleen H., 2017. "Cost effectiveness of medical devices to diagnose pre-eclampsia in low-resource settings," Development Engineering, Elsevier, vol. 2(C), pages 99-106.
  62. George J Milne & Nilimesh Halder & Joel K Kelso, 2013. "The Cost Effectiveness of Pandemic Influenza Interventions: A Pandemic Severity Based Analysis," PLOS ONE, Public Library of Science, vol. 8(4), pages 1-16, April.
  63. Marilys Victoire Razakamanana & Martine Audibert & Tantely Andrianantoandro & Aina Harimanana, 2017. "Impact and Efficiency of the Integration of Diagnosis and Treatment of Pneumonia in Malaria Community Case Management in Madagascar," CERDI Working papers halshs-01479210, HAL.
  64. Paul Gavaza & Karen Rascati & Abiola Oladapo & Star Khoza, 2012. "The State of Health Economic Research in South Africa," PharmacoEconomics, Springer, vol. 30(10), pages 925-940, October.
  65. Round, Jeff, 2012. "Is a QALY still a QALY at the end of life?," Journal of Health Economics, Elsevier, vol. 31(3), pages 521-527.
  66. Eduard Vrdoljak & Mario Sekerija & Stjepko Plestina & Ingrid Belac Lovasic & Vera Katalinic Jankovic & Livio Garattini & Ana Bobinac & Luka Voncina, 2021. "Is it too expensive to fight cancer? Analysis of incremental costs and benefits of the Croatian National Plan Against Cancer," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(3), pages 393-403, April.
  67. Benjarin Santatiwongchai & Varit Chantarastapornchit & Thomas Wilkinson & Kittiphong Thiboonboon & Waranya Rattanavipapong & Damian G Walker & Kalipso Chalkidou & Yot Teerawattananon, 2015. "Methodological Variation in Economic Evaluations Conducted in Low- and Middle-Income Countries: Information for Reference Case Development," PLOS ONE, Public Library of Science, vol. 10(5), pages 1-15, May.
  68. Wanitchaya Kittikraisak & Piyarat Suntarattiwong & Darunee Ditsungnoen & Sarah E Pallas & Taiwo O Abimbola & Chonticha Klungthong & Stefan Fernandez & Suchada Srisarang & Tawee Chotpitayasunondh & Fat, 2017. "Cost-effectiveness of inactivated seasonal influenza vaccination in a cohort of Thai children ≤60 months of age," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-15, August.
  69. Reka E. Pataky & Stirling Bryan & Mohsen Sadatsafavi & Stuart Peacock & Dean A. Regier, 2022. "Tools for the Economic Evaluation of Precision Medicine: A Scoping Review of Frameworks for Valuing Heterogeneity-Informed Decisions," PharmacoEconomics, Springer, vol. 40(10), pages 931-941, October.
  70. Freekje van Asten & Charlotte T J Michels & Carel B Hoyng & Gert Jan van der Wilt & B Jeroen Klevering & Maroeska M Rovers & Janneke P C Grutters, 2018. "The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration—A cost-effectiveness analysis from a societal perspective," PLOS ONE, Public Library of Science, vol. 13(5), pages 1-14, May.
  71. Oliver Fritz & Peter Mayerhofer & Reinhard Haller & Gerhard Streicher & Florian Bachner & Herwig Ostermann, 2013. "Die regionalwirtschaftlichen Effekte der österreichischen Krankenanstalten," WIFO Studies, WIFO, number 46672, February.
  72. Weatherly, Helen & Drummond, Michael & Claxton, Karl & Cookson, Richard & Ferguson, Brian & Godfrey, Christine & Rice, Nigel & Sculpher, Mark & Sowden, Amanda, 2009. "Methods for assessing the cost-effectiveness of public health interventions: Key challenges and recommendations," Health Policy, Elsevier, vol. 93(2-3), pages 85-92, December.
  73. Ties Hoomans & Johan L. Severens & Silvia M. A. A. Evers & Andre J. H. A. Ament, 2009. "Value for Money in Changing Clinical Practice: Should Decisions about Guidelines and Implementation Strategies Be Made Sequentially or Simultaneously?," Medical Decision Making, , vol. 29(2), pages 207-216, March.
  74. Roslyn E. Donnellan-Fernandez & Debra K. Creedy & Emily J. Callander, 2018. "Cost-effectiveness of continuity of midwifery care for women with complex pregnancy: a structured review of the literature," Health Economics Review, Springer, vol. 8(1), pages 1-16, December.
  75. Bettina Wulff Risør & Marianne Lisby & Jan Sørensen, 2018. "Comparative Cost-Effectiveness Analysis of Three Different Automated Medication Systems Implemented in a Danish Hospital Setting," Applied Health Economics and Health Policy, Springer, vol. 16(1), pages 91-106, February.
  76. Ilias Goranitis & Joanna Coast & Ed Day & Alex Copello & Nick Freemantle & Emma Frew, 2017. "Maximizing Health or Sufficient Capability in Economic Evaluation? A Methodological Experiment of Treatment for Drug Addiction," Medical Decision Making, , vol. 37(5), pages 498-511, July.
  77. Emil Victor Gruber & Stephanie Stock & Björn Stollenwerk, 2012. "Breast Cancer Attributable Costs in Germany: A Top-Down Approach Based on Sickness Funds Data," PLOS ONE, Public Library of Science, vol. 7(12), pages 1-6, December.
  78. Ulrikke J. V. Hernæs & Kjell A. Johansson & Trygve Ottersen & Ole F. Norheim, 2017. "Distribution-Weighted Cost-Effectiveness Analysis Using Lifetime Health Loss," PharmacoEconomics, Springer, vol. 35(9), pages 965-974, September.
  79. Jeff Richardson & Angelo Iezzi & Aimee Maxwell, 2017. "How important is severity for the evaluation of health services: new evidence using the relative social willingness to pay instrument," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(6), pages 671-683, July.
  80. Andronis, Lazaros & Morgan, Cameron & Donaldson, Cam & Lancsar, Emily & Petrou, Stavros, 2023. "Views, obstacles, and uncertainties around the inclusion of children and young people's time in economic evaluations: Findings from an international survey of health economists," Social Science & Medicine, Elsevier, vol. 333(C).
  81. Lungiswa Leonora Nkonki & Emmanuelle Daviaud & Debra Jackson & Lumbwe Chola & Tanya Doherty & Mickey Chopra & Bjarne Robberstad & for the Promise-EBF Study Group, 2014. "Costs of Promoting Exclusive Breastfeeding at Community Level in Three Sites in South Africa," PLOS ONE, Public Library of Science, vol. 9(1), pages 1-9, January.
  82. Garry R. Barton & Tracey H. Sach & Anthony J. Avery & Claire Jenkinson & Michael Doherty & David K. Whynes & Kenneth R. Muir, 2008. "A comparison of the performance of the EQ‐5D and SF‐6D for individuals aged ≥ 45 years," Health Economics, John Wiley & Sons, Ltd., vol. 17(7), pages 815-832, July.
  83. Marscha S. Holleman & Maiwenn J. Al & Remziye Zaim & Harry J. M. Groen & Carin A. Uyl-de Groot, 2020. "Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with non-small cell lung cancer harbouring EGFR mutations," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(1), pages 153-164, February.
  84. Jonathan Karnon & Hossein Haji Ali Afzali, 2014. "When to Use Discrete Event Simulation (DES) for the Economic Evaluation of Health Technologies? A Review and Critique of the Costs and Benefits of DES," PharmacoEconomics, Springer, vol. 32(6), pages 547-558, June.
  85. Rachel Meacock & Søren Rud Kristensen & Matt Sutton, 2014. "The Cost‐Effectiveness Of Using Financial Incentives To Improve Provider Quality: A Framework And Application," Health Economics, John Wiley & Sons, Ltd., vol. 23(1), pages 1-13, January.
  86. Samer Kharroubi, 2015. "A Comparison of Japan and UK SF-6D Health-State Valuations Using a Non-Parametric Bayesian Method," Applied Health Economics and Health Policy, Springer, vol. 13(4), pages 409-420, August.
  87. A. Newall & M. Jit & R. Hutubessy, 2014. "Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines," PharmacoEconomics, Springer, vol. 32(6), pages 525-531, June.
  88. Yesim Tozan & Pitcha Ratanawong & Valérie R Louis & Pattamaporn Kittayapong & Annelies Wilder-Smith, 2014. "Use of Insecticide-Treated School Uniforms for Prevention of Dengue in Schoolchildren: A Cost-Effectiveness Analysis," PLOS ONE, Public Library of Science, vol. 9(9), pages 1-9, September.
  89. Giulia Greco & Paula Lorgelly & Inthira Yamabhai, 2016. "Outcomes in Economic Evaluations of Public Health Interventions in Low‐ and Middle‐Income Countries: Health, Capabilities and Subjective Wellbeing," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 83-94, February.
  90. Martin Forster & Emanuela Randon, 2020. "Epidemic policy under uncertainty and information," Discussion Papers 20/05, Department of Economics, University of York.
  91. Claudine de Meijer & Werner Brouwer & Marc Koopmanschap & Bernard van den Berg & Job van Exel, 2010. "The value of informal care–a further investigation of the feasibility of contingent valuation in informal caregivers," Health Economics, John Wiley & Sons, Ltd., vol. 19(7), pages 755-771, July.
  92. Ching-Yun Wei & Ruben G. W. Quek & Guillermo Villa & Shravanthi R. Gandra & Carol A. Forbes & Steve Ryder & Nigel Armstrong & Sohan Deshpande & Steven Duffy & Jos Kleijnen & Peter Lindgren, 2017. "A Systematic Review of Cardiovascular Outcomes-Based Cost-Effectiveness Analyses of Lipid-Lowering Therapies," PharmacoEconomics, Springer, vol. 35(3), pages 297-318, March.
  93. Oguzhan Alagoz & Jagpreet Chhatwal & Elizabeth S. Burnside, 2013. "Optimal Policies for Reducing Unnecessary Follow-Up Mammography Exams in Breast Cancer Diagnosis," Decision Analysis, INFORMS, vol. 10(3), pages 200-224, September.
  94. Diana Sonntag, 2014. "FUNDING HIV‐VACCINE RESEARCH IN DEVELOPING COUNTRIES—WHAT IS WRONG WITH IAVI's RECOMMENDATION?," Health Economics, John Wiley & Sons, Ltd., vol. 23(2), pages 141-158, February.
  95. Karl Claxton & Simon Walker & Steven Palmer & Mark Sculpher, 2010. "Appropriate Perspectives for Health Care Decisions," Working Papers 054cherp, Centre for Health Economics, University of York.
  96. Miqdad Asaria & Susan Griffin & Richard Cookson & Sophie Whyte & Paul Tappenden, 2013. "Distributional Cost-Effectiveness Analysis of Health Care Programmes," Working Papers 091cherp, Centre for Health Economics, University of York.
  97. Eva Rodríguez Míguez & José María Abellán Perpiñán & José Carlos Álvarez Villamarín & José Manuel González Martínez & Antonio Rodríguez Sampayo, 2013. "Development of a new preference-based instrument to measure dependency," Working Papers 1301, Universidade de Vigo, Departamento de Economía Aplicada.
  98. Philip Kinghorn & Joanna Coast, 2018. "Assessing the capability to experience a 'good death': A qualitative study to directly elicit expert views on a new supportive care measure grounded in Sen's capability approach," PLOS ONE, Public Library of Science, vol. 13(2), pages 1-14, February.
  99. Frida Ngalesoni & George Ruhago & Mary Mayige & Tiago Cravo Oliveira & Bjarne Robberstad & Ole Frithjof Norheim & Hideki Higashi, 2017. "Cost-effectiveness analysis of population-based tobacco control strategies in the prevention of cardiovascular diseases in Tanzania," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-20, August.
  100. Jacob Smith, 2023. "Considering Risk Aversion in Economic Evaluation: A Rank Dependent Approach," Papers 2311.07905, arXiv.org, revised Jan 2024.
  101. Carmine Rossi & Kevin Schwartzman & Olivia Oxlade & Marina B Klein & Chris Greenaway, 2013. "Hepatitis B Screening and Vaccination Strategies for Newly Arrived Adult Canadian Immigrants and Refugees: A Cost-Effectiveness Analysis," PLOS ONE, Public Library of Science, vol. 8(10), pages 1-1, October.
  102. John Brazier & Donna Rowen & Yaling Yang & Aki Tsuchiya, 2012. "Comparison of health state utility values derived using time trade-off, rank and discrete choice data anchored on the full health-dead scale," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(5), pages 575-587, October.
  103. Jose L Burgos & Thomas L Patterson & Joshua S Graff-Zivin & James G Kahn & M Gudelia Rangel & M Remedios Lozada & Hugo Staines & Steffanie A Strathdee, 2016. "Cost-Effectiveness of Combined Sexual and Injection Risk Reduction Interventions among Female Sex Workers Who Inject Drugs in Two Very Distinct Mexican Border Cities," PLOS ONE, Public Library of Science, vol. 11(2), pages 1-15, February.
  104. Hoa‐Thi‐Minh Nguyen & Tom Kompas & Roslyn I. Hickson, 2014. "Aid and the Control of Tuberculosis in Papua New Guinea: Is Australia's Assistance Cost‐Effective?," Asia and the Pacific Policy Studies, Wiley Blackwell, vol. 1(2), pages 364-378, May.
  105. Kim M. Dalziel & Dale Halliday & Leonie Segal, 2015. "Assessment of the Cost–Benefit Literature on Early Childhood Education for Vulnerable Children," SAGE Open, , vol. 5(1), pages 21582440155, February.
  106. Nathalie Havet & Magali Morelle & Alexis Penot & Raphaël Remonnay, 2012. "The information content of the WTP-WTA gap: An empirical analysis among severely ill patients," Working Papers 1213, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  107. Keel, George & Savage, Carl & Rafiq, Muhammad & Mazzocato, Pamela, 2017. "Time-driven activity-based costing in health care: A systematic review of the literature," Health Policy, Elsevier, vol. 121(7), pages 755-763.
  108. James Buchanan & Sarah Wordsworth & Ruth Clifford & Pauline Robbe & Jenny C. Taylor & Anna Schuh & Samantha J. L. Knight, 2017. "Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis," PharmacoEconomics, Springer, vol. 35(8), pages 845-858, August.
  109. Renske J. Hoefman & Job Exel & Werner B. F. Brouwer, 2017. "Measuring Care-Related Quality of Life of Caregivers for Use in Economic Evaluations: CarerQol Tariffs for Australia, Germany, Sweden, UK, and US," PharmacoEconomics, Springer, vol. 35(4), pages 469-478, April.
  110. Silke B. Wolfenstetter & Christina M. Wenig, 2010. "Economic Evaluation and Transferability of Physical Activity Programmes in Primary Prevention: A Systematic Review," IJERPH, MDPI, vol. 7(4), pages 1-27, April.
  111. Ofra Golan & Paul Hansen & Giora Kaplan & Orna Tal, 2010. "Health Technology Prioritisation: Which criteria for prioritising new technologies, and what are their relative weights?," Working Papers 1006, University of Otago, Department of Economics, revised Jul 2010.
  112. Raymond Oppong & Billingsley Kaambwa & Jacqueline Nuttall & Kerenza Hood & Richard Smith & Joanna Coast, 2013. "The impact of using different tariffs to value EQ-5D health state descriptions: an example from a study of acute cough/lower respiratory tract infections in seven countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(2), pages 197-209, April.
  113. Najmiatul Fitria & Antoinette D. I. Asselt & Maarten J. Postma, 2019. "Cost-effectiveness of controlling gestational diabetes mellitus: a systematic review," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 407-417, April.
  114. Herlitz, Anders & Horan, David, 2016. "Measuring needs for priority setting in healthcare planning and policy," Social Science & Medicine, Elsevier, vol. 157(C), pages 96-102.
  115. Lisa A Prosser & Tara A Lavelle & Anthony E Fiore & Carolyn B Bridges & Carrie Reed & Seema Jain & Kelly M Dunham & Martin I Meltzer, 2011. "Cost-Effectiveness of 2009 Pandemic Influenza A(H1N1) Vaccination in the United States," PLOS ONE, Public Library of Science, vol. 6(7), pages 1-11, July.
  116. Lynch, Frances L. & Dickerson, John F. & Pears, Katherine C. & Fisher, Philip A., 2017. "Cost effectiveness of a school readiness intervention for foster children," Children and Youth Services Review, Elsevier, vol. 81(C), pages 63-71.
  117. Lijun Fan & Bill Lukin & Jingzhou Zhao & Jiandong Sun & Kaeleen Dingle & Rhonda Purtill & Sam Tapp & Xiang-Yu Hou, 2018. "Cost analysis of improving emergency care for aged care residents under a Hospital in the Nursing Home program in Australia," PLOS ONE, Public Library of Science, vol. 13(7), pages 1-17, July.
  118. Alice Zwerling & Richard G White & Anna Vassall & Ted Cohen & David W Dowdy & Rein M G J Houben, 2014. "Modeling of Novel Diagnostic Strategies for Active Tuberculosis – A Systematic Review: Current Practices and Recommendations," PLOS ONE, Public Library of Science, vol. 9(10), pages 1-8, October.
  119. Thomas Grochtdreis & Hans-Helmut König & Alexander Dobruschkin & Gunhild von Amsberg & Judith Dams, 2018. "Cost-effectiveness analyses and cost analyses in castration-resistant prostate cancer: A systematic review," PLOS ONE, Public Library of Science, vol. 13(12), pages 1-25, December.
  120. Rosarin Sruamsiri & Piyameth Dilokthornsakul & Chayanin Pratoomsoot & Nathorn Chaiyakunapruk, 2014. "A Cost-effectiveness Study of Intravenous Immunoglobulin in Childhood Idiopathic Thrombocytopenia Purpura Patients with Life-Threatening Bleeding," PharmacoEconomics, Springer, vol. 32(8), pages 801-813, August.
  121. Elza Daoud & Charlotte Caimino & Michael A. Akeroyd & Arnaud J. Noreña & David M. Baguley, 2022. "The Utility of Economic Measures to Quantify the Burden of Tinnitus in Affected Individuals: A Scoping Review," PharmacoEconomics - Open, Springer, vol. 6(1), pages 21-32, January.
  122. Goebbels, Adrienne F.G. & Lakerveld, Jeroen & Ament, André J.H.A. & Bot, Sandra D.M. & Severens, Johan L., 2012. "Exploring non-health outcomes of health promotion: The perspective of participants in a lifestyle behaviour change intervention," Health Policy, Elsevier, vol. 106(2), pages 177-186.
  123. Luís Azevedo & Altamiro Costa-Pereira & Liliane Mendonça & Cláudia Dias & José Castro-Lopes, 2016. "The economic impact of chronic pain: a nationwide population-based cost-of-illness study in Portugal," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 87-98, January.
  124. Nicolas A Menzies & Andres A Berruti & John M Blandford, 2012. "The Determinants of HIV Treatment Costs in Resource Limited Settings," PLOS ONE, Public Library of Science, vol. 7(11), pages 1-9, November.
  125. Kate A Halton & David Cook & David L Paterson & Nasia Safdar & Nicholas Graves, 2010. "Cost-Effectiveness of a Central Venous Catheter Care Bundle," PLOS ONE, Public Library of Science, vol. 5(9), pages 1-11, September.
  126. Boone, J., 2014. "Basic Versus Supplementary Health Insurance : Moral Hazard and Adverse Selection," Other publications TiSEM 6bf0e55c-e004-4c9e-8065-6, Tilburg University, School of Economics and Management.
  127. Hideki Higashi & Khoa Truong & Jan Barendregt & Phuong Nguyen & Mai Vuong & Thuy Nguyen & Phuong Hoang & Angela Wallace & Tien Tran & Cuong Le & Christopher Doran, 2011. "Cost effectiveness of tobacco control policies in Vietnam," Applied Health Economics and Health Policy, Springer, vol. 9(3), pages 183-196, May.
  128. Govorun, Maria & Latouche, Guy & Loisel, Stéphane, 2015. "Phase-type aging modeling for health dependent costs," Insurance: Mathematics and Economics, Elsevier, vol. 62(C), pages 173-183.
  129. Mei-Chuan Hung & Hsin-Ming Lu & Likwang Chen & Ming-Shian Lin & Cheng-Ren Chen & Chong-Jen Yu & Jung-Der Wang, 2012. "Cost per QALY (Quality-Adjusted Life Year) and Lifetime Cost of Prolonged Mechanical Ventilation in Taiwan," PLOS ONE, Public Library of Science, vol. 7(9), pages 1-10, September.
  130. Adam Fridhammar & Ulrika Axelsson & Ulf Persson & Anders Bjartell & Carl A. K. Borrebaeck, 2021. "The Value of a New Diagnostic Test for Prostate Cancer: A Cost-Utility Analysis in Early Stage of Development," PharmacoEconomics - Open, Springer, vol. 5(1), pages 77-88, March.
  131. Mike Paulden & Karl Claxton, 2012. "Budget allocation and the revealed social rate of time preference for health," Health Economics, John Wiley & Sons, Ltd., vol. 21(5), pages 612-618, May.
  132. La’Marcus T Wingate & Margaret S Coleman & Drew L Posey & Weigong Zhou & Christine K Olson & Brian Maskery & Martin S Cetron & John A Painter, 2015. "Cost-Effectiveness of Screening and Treating Foreign-Born Students for Tuberculosis before Entering the United States," PLOS ONE, Public Library of Science, vol. 10(4), pages 1-19, April.
  133. Fuhmei Wang, 2021. "The Influences of Prevention on the Quality of Life," Applied Research in Quality of Life, Springer;International Society for Quality-of-Life Studies, vol. 16(1), pages 129-139, February.
  134. Luqman Tariq & Matthijs van den Berg & Rudolf T Hoogenveen & Pieter H M van Baal, 2009. "Cost-Effectiveness of an Opportunistic Screening Programme and Brief Intervention for Excessive Alcohol Use in Primary Care," PLOS ONE, Public Library of Science, vol. 4(5), pages 1-8, May.
  135. Kim Jeong & John Cairns, 2013. "Review of economic evidence in the prevention and early detection of colorectal cancer," Health Economics Review, Springer, vol. 3(1), pages 1-10, December.
  136. Steven M. Shechter, 2011. "Treatment Evolution and New Standards of Care," Medical Decision Making, , vol. 31(1), pages 35-42, January.
  137. Christian Schader & Jürn Sanders & Thomas Nemecek & Nic Lampkin & Matthias Stolze, 2008. "A Modelling Approach for Evaluating Agri-Environmental Policies at Sector Level," Journal of Socio-Economics in Agriculture (Until 2015: Yearbook of Socioeconomics in Agriculture), Swiss Society for Agricultural Economics and Rural Sociology, vol. 1(1), pages 93-132.
  138. Andrija S Grustam & Nasuh Buyukkaramikli & Ron Koymans & Hubertus J M Vrijhoef & Johan L Severens, 2019. "Value of information analysis in telehealth for chronic heart failure management," PLOS ONE, Public Library of Science, vol. 14(6), pages 1-23, June.
  139. Leo Nherera & Barrett Larson & Annemari Cooley & Patrick Reinhard, 2021. "An economic analysis of a wearable patient sensor for preventing hospital-acquired pressure injuries among the acutely ill patients," International Journal of Health Economics and Management, Springer, vol. 21(4), pages 457-471, December.
  140. Søgaard, Rikke & Kløjgaard, Mirja Elisabeth & Olsen, Jens, 2010. "Methods for cost-effectiveness evaluation alongside trials in spine surgery," DaCHE discussion papers 2010:5, University of Southern Denmark, Dache - Danish Centre for Health Economics.
  141. Victoria Brennan & Simon Dixon, 2013. "Incorporating Process Utility into Quality Adjusted Life Years: A Systematic Review of Empirical Studies," PharmacoEconomics, Springer, vol. 31(8), pages 677-691, August.
  142. Georgina Jones & Victoria Brennan & Richard Jacques & Hilary Wood & Simon Dixon & Stephen Radley, 2018. "Evaluating the impact of a ‘virtual clinic’ on patient experience, personal and provider costs of care in urinary incontinence: A randomised controlled trial," PLOS ONE, Public Library of Science, vol. 13(1), pages 1-16, January.
  143. Susan Griffin & Helen Weatherly & Gerry Richardson & Mike Drummond, 2008. "Methodological issues in undertaking independent cost-effectiveness analysis for NICE: the case of therapies for ADHD," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 9(2), pages 137-145, May.
  144. Bae, Green & Bae, Eun Young & Bae, SeungJin, 2015. "Same drugs, valued differently? Comparing comparators and methods used in reimbursement recommendations in Australia, Canada, and Korea," Health Policy, Elsevier, vol. 119(5), pages 577-587.
  145. Pieter van Baal & David Meltzer & Werner Brouwer, 2016. "Future Costs, Fixed Healthcare Budgets, and the Decision Rules of Cost‐Effectiveness Analysis," Health Economics, John Wiley & Sons, Ltd., vol. 25(2), pages 237-248, February.
  146. William Wong & Josh Carlson & Rahber Thariani & David Veenstra, 2010. "Cost Effectiveness of Pharmacogenomics," PharmacoEconomics, Springer, vol. 28(11), pages 1001-1013, November.
  147. Virginia Wiseman & Craig Mitton & Mary M. Doyle‐Waters & Tom Drake & Lesong Conteh & Anthony T. Newall & Obinna Onwujekwe & Stephen Jan, 2016. "Using Economic Evidence to Set Healthcare Priorities in Low‐Income and Lower‐Middle‐Income Countries: A Systematic Review of Methodological Frameworks," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 140-161, February.
  148. Fernando Alarid-Escudero & Karen M. Kuntz, 2020. "Potential Bias Associated with Modeling the Effectiveness of Healthcare Interventions in Reducing Mortality Using an Overall Hazard Ratio," PharmacoEconomics, Springer, vol. 38(3), pages 285-296, March.
  149. Moreno, Elías & Girón, F.J. & Vázquez-Polo, F.J. & NegrI´n, M.A., 2010. "Optimal healthcare decisions: Comparing medical treatments on a cost-effectiveness basis," European Journal of Operational Research, Elsevier, vol. 204(1), pages 180-187, July.
  150. Fleurbaey, Marc & Zuber, Stéphane, 2017. "Fair management of social risk," Journal of Economic Theory, Elsevier, vol. 169(C), pages 666-706.
  151. Maxwell Ayindenaba Dalaba & Paul Welaga & Abraham Oduro & Laata Latif Danchaka & Chieko Matsubara, 2018. "Cost of malaria treatment and health seeking behaviour of children under-five years in the Upper West Region of Ghana," PLOS ONE, Public Library of Science, vol. 13(4), pages 1-14, April.
  152. Marianna Cavazza & Yllka Kodra & Patrizio Armeni & Marta De Santis & Julio López-Bastida & Renata Linertová & Juan Oliva-Moreno & Pedro Serrano-Aguilar & Manuel Posada-de-la-Paz & Domenica Taruscio & , 2016. "Social/economic costs and quality of life in patients with haemophilia in Europe," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 53-65, April.
  153. G. Sagoo & S. Mohammed & G. Barton & G. Norbury & J. Ahn & C. Ogilvie & M. Kroese, 2015. "Cost Effectiveness of Using Array-CGH for Diagnosing Learning Disability," Applied Health Economics and Health Policy, Springer, vol. 13(4), pages 421-432, August.
  154. Turgay Ayer, 2015. "Inverse optimization for assessing emerging technologies in breast cancer screening," Annals of Operations Research, Springer, vol. 230(1), pages 57-85, July.
  155. Julie Ratcliffe & Leah Couzner & Terry Flynn & Michael Sawyer & Katherine Stevens & John Brazier & Leonie Burgess, 2011. "Valuing child health utility 9D health states with a young adolescent sample," Applied Health Economics and Health Policy, Springer, vol. 9(1), pages 15-27, January.
  156. Andreas Kirisits & W. Redekop, 2013. "The Economic Evaluation of Medical Devices," Applied Health Economics and Health Policy, Springer, vol. 11(1), pages 15-26, February.
  157. Daisuke Goto & Ya-Chen Tina Shih & Pascal Lecomte & Melvin Olson & Chukwukadibia Udeze & Yujin Park & C. Daniel Mullins, 2017. "Regression-Based Approaches to Patient-Centered Cost-Effectiveness Analysis," PharmacoEconomics, Springer, vol. 35(7), pages 685-695, July.
  158. Lotte Soeteman & Job Exel & Ana Bobinac, 2017. "The impact of the design of payment scales on the willingness to pay for health gains," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(6), pages 743-760, July.
  159. O'Hagan, A & Brazier, JE & Kharroubi, SA, 2007. "A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method," MPRA Paper 29806, University Library of Munich, Germany.
  160. Anne Magnus & Linda Cobiac & Julie Brimblecombe & Mark Chatfield & Anthony Gunther & Megan Ferguson & Marj Moodie, 2018. "The cost-effectiveness of a 20% price discount on fruit, vegetables, diet drinks and water, trialled in remote Australia to improve Indigenous health," PLOS ONE, Public Library of Science, vol. 13(9), pages 1-19, September.
  161. Williams, Iestyn & Bryan, Stirling, 2007. "Understanding the limited impact of economic evaluation in health care resource allocation: A conceptual framework," Health Policy, Elsevier, vol. 80(1), pages 135-143, January.
  162. Richard D. Smith, 2008. "Contingent valuation in health care: does it matter how the ‘good’ is described?," Health Economics, John Wiley & Sons, Ltd., vol. 17(5), pages 607-617, May.
  163. Afschin Gandjour, 2008. "Incorporating feelings related to the uncertainty about future health in utility measurement," Health Economics, John Wiley & Sons, Ltd., vol. 17(10), pages 1207-1213, October.
  164. Mulhern, B & Smith, SC & Rowen, D & Brazier, JE & Knapp, M & Lamping, DL & Loftus, V & Young, Tracey A. & Howard, RJ & Banerjee, S, 2010. "Improving the measurement of QALYs in dementia: developing patient- and carer-reported health state classification systems using Rasch analysis," MPRA Paper 29948, University Library of Munich, Germany.
  165. Shu‐Fen Lo & Yun‐Tung Wang & Li‐Yue Wu & Mei‐Yu Hsu & Shu‐Chuan Chang & Mark Hayter, 2010. "A cost–effectiveness analysis of a multimedia learning education program for stoma patients," Journal of Clinical Nursing, John Wiley & Sons, vol. 19(13‐14), pages 1844-1854, July.
  166. Olivia Ernstsson & Hanna Gyllensten & Kristina Alexanderson & Petter Tinghög & Emilie Friberg & Anders Norlund, 2016. "Cost of Illness of Multiple Sclerosis - A Systematic Review," PLOS ONE, Public Library of Science, vol. 11(7), pages 1-25, July.
  167. Hartz, Susanne & John, Jürgen, 2009. "Public health policy decisions on medical innovations: What role can early economic evaluation play?," Health Policy, Elsevier, vol. 89(2), pages 184-192, February.
  168. Gijs Van de Wetering & Willem H. Woertman & Eddy M. M. Adang, 2012. "A model to correct for short‐run inefficiencies in economic evaluations in healthcare," Health Economics, John Wiley & Sons, Ltd., vol. 21(3), pages 270-281, March.
  169. Voahirana T Andrianantoandro & Martine Audibert & Thomas Kesteman & Léonora Ravolanjarasoa & Milijaona Randrianarivelojosia & Christophe Rogier & Milijaona Randrianarivelojosia Researcher, 2021. "Cost of the national malaria control program and cost-effectiveness of indoor residual spraying and insecticide-treated bed nets strategies in two districts of Madagascar," CERDI Working papers hal-03249411, HAL.
  170. Eleanor Heather & Katherine Payne & Mark Harrison & Deborah Symmons, 2014. "Including Adverse Drug Events in Economic Evaluations of Anti-Tumour Necrosis Factor-α Drugs for Adult Rheumatoid Arthritis: A Systematic Review of Economic Decision Analytic Models," PharmacoEconomics, Springer, vol. 32(2), pages 109-134, February.
  171. Tomoyuki Takura & Hiroko Miura, 2022. "Socioeconomic Determinants of Universal Health Coverage in the Asian Region," IJERPH, MDPI, vol. 19(4), pages 1-15, February.
  172. Pooja Desai & Hitesh Chandwani & Karen Rascati, 2012. "Assessing the Quality of Pharmacoeconomic Studies in India," PharmacoEconomics, Springer, vol. 30(9), pages 749-762, September.
  173. Liliana Barbu, 2023. "Global trends in the scientific research of the health economics: a bibliometric analysis from 1975 to 2022," Health Economics Review, Springer, vol. 13(1), pages 1-20, December.
  174. Olalekan A Uthman & Taiwo Aderemi Popoola & Mubashir M B Uthman & Olatunde Aremu, 2010. "Economic Evaluations of Adult Male Circumcision for Prevention of Heterosexual Acquisition of HIV in Men in Sub-Saharan Africa: A Systematic Review," PLOS ONE, Public Library of Science, vol. 5(3), pages 1-7, March.
  175. Makai, Peter & Brouwer, Werner B.F. & Koopmanschap, Marc A. & Stolk, Elly A. & Nieboer, Anna P., 2014. "Quality of life instruments for economic evaluations in health and social care for older people: A systematic review," Social Science & Medicine, Elsevier, vol. 102(C), pages 83-93.
  176. Nathalie Havet & Magali Morelle & Raphaël Remonnay & Marie-Odile Carrere, 2012. "Cancer patients’ willingness to pay for blood transfusions at home: results from a contingent valuation study in a French cancer network," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(3), pages 289-300, June.
  177. Claire Williams & James D. Lewsey & Andrew H. Briggs & Daniel F. Mackay, 2017. "Cost-effectiveness Analysis in R Using a Multi-state Modeling Survival Analysis Framework: A Tutorial," Medical Decision Making, , vol. 37(4), pages 340-352, May.
  178. Mohsen Sadatsafavi; & Carlo Marra; & Lawrence McCandless & Stirling Bryan, 2012. "The challenge of incorporating external evidence in trial-based cost-effectiveness analyses: the use of resampling methods," Health, Econometrics and Data Group (HEDG) Working Papers 12/24, HEDG, c/o Department of Economics, University of York.
  179. Dimitrios Rovithis, 2013. "Do health economic evaluations using observational data provide reliable assessment of treatment effects?," Health Economics Review, Springer, vol. 3(1), pages 1-7, December.
  180. Lisa Prosser & Katherine Payne & Donna Rusinak & Ping Shi & Mark Messonnier, 2013. "Using a Discrete Choice Experiment to Elicit Time Trade-Off and Willingness-to-Pay Amounts for Influenza Health-Related Quality of Life at Different Ages," PharmacoEconomics, Springer, vol. 31(4), pages 305-315, April.
  181. Sanghera, Sabina & Frew, Emma & Kai, Joe & Gupta, Janesh & Elizabeth Roberts, Tracy, 2013. "An assessment of economic measures used in menorrhagia: A systematic review," Social Science & Medicine, Elsevier, vol. 98(C), pages 149-153.
  182. Steven Simoens, 2009. "Health Economic Assessment: A Methodological Primer," IJERPH, MDPI, vol. 6(12), pages 1-17, November.
  183. Boone, J., 2014. "Basic versus Supplementary Health Insurance : The Role of Cost Effectiveness and Prevalence," Discussion Paper 2014-065, Tilburg University, Center for Economic Research.
  184. Marike R. C. Hendriks & Maiwenn J. Al & Michel H. C. Bleijlevens & Jolanda C. M. van Haastregt & Harry F. J. M. Crebolder & Jacques Th. M. van Eijk & Silvia M. A. A. Evers, 2013. "Continuous versus Intermittent Data Collection of Health Care Utilization," Medical Decision Making, , vol. 33(8), pages 998-1008, November.
  185. Marieke Krol & Jocé Papenburg & Marc Koopmanschap & Werner Brouwer, 2011. "Do Productivity Costs Matter?," PharmacoEconomics, Springer, vol. 29(7), pages 601-619, July.
  186. Brooke E Nichols & Charles A B Boucher & Janneke H van Dijk & Phil E Thuma & Jan L Nouwen & Rob Baltussen & Janneke van de Wijgert & Peter M A Sloot & David A M C van de Vijver, 2013. "Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) in Preventing HIV-1 Infections in Rural Zambia: A Modeling Study," PLOS ONE, Public Library of Science, vol. 8(3), pages 1-10, March.
  187. Philipp Auweiler & Dirk Müller & Stephanie Stock & Andreas Gerber, 2012. "Cost Effectiveness of Rituximab for Non-Hodgkin’s Lymphoma," PharmacoEconomics, Springer, vol. 30(7), pages 537-549, July.
  188. Tom L. Drake & Yoel Lubell & Shwe Sin Kyaw & Angela Devine & Myat Phone Kyaw & Nicholas P. J. Day & Frank M. Smithuis & Lisa J. White, 2017. "Geographic Resource Allocation Based on Cost Effectiveness: An Application to Malaria Policy," Applied Health Economics and Health Policy, Springer, vol. 15(3), pages 299-306, June.
  189. Heckley, Gawain A. & Gerdtham, Ulf-G. & Kjellsson, Gustav, 2014. "A New Approach to Decomposition of a Bivariate Rank Dependent Index Using Recentered Influence Function Regression," Working Papers 2014:36, Lund University, Department of Economics, revised 01 Apr 2015.
  190. Christian Brettschneider & Steffi Riedel-Heller & Hans-Helmut König, 2014. "A Systematic Review of Economic Evaluations of Treatments for Borderline Personality Disorder," PLOS ONE, Public Library of Science, vol. 9(9), pages 1-12, September.
  191. Manuel Gomes & Robert Aldridge & Peter Wylie & James Bell & Owen Epstein, 2013. "Cost-Effectiveness Analysis of 3-D Computerized Tomography Colonography Versus Optical Colonoscopy for Imaging Symptomatic Gastroenterology Patients," Applied Health Economics and Health Policy, Springer, vol. 11(2), pages 107-117, April.
  192. Lazaros Andronis & Ilias Goranitis & Sue Bayliss & Rui Duarte, 2018. "Cost-Effectiveness of Treatments for the Management of Bone Metastases: A Systematic Literature Review," PharmacoEconomics, Springer, vol. 36(3), pages 301-322, March.
  193. Voahirana T Andrianantoandro & Martine Audibert & Thomas Kesteman & Léonora Ravolanjarasoa & Milijaona Randrianarivelojosia & Christophe Rogier & Milijaona Randrianarivelojosia Researcher, 2021. "Cost of the national malaria control program and cost-effectiveness of indoor residual spraying and insecticide-treated bed nets strategies in two districts of Madagascar," Working Papers hal-03249411, HAL.
  194. Helen Dakin & Sarah Wordsworth, 2013. "Cost‐Minimisation Analysis Versus Cost‐Effectiveness Analysis, Revisited," Health Economics, John Wiley & Sons, Ltd., vol. 22(1), pages 22-34, January.
  195. Kurubaran Ganasegeran & Chee Peng Hor & Mohd Fadzly Amar Jamil & Hong Chuan Loh & Juliana Mohd Noor & Norshahida Abdul Hamid & Purnima Devi Suppiah & Mohd Rizal Abdul Manaf & Alan Swee Hock Ch’ng & Ir, 2020. "A Systematic Review of the Economic Burden of Type 2 Diabetes in Malaysia," IJERPH, MDPI, vol. 17(16), pages 1-23, August.
  196. Mathieu F. Janssen & Erwin Birnie & Gouke Bonsel, 2008. "Feasibility and Reliability of the Annual Profile Method for Deriving QALYs for Short-Term Health Conditions," Medical Decision Making, , vol. 28(4), pages 500-510, July.
  197. Callan, Aoife & O'Shea, Eamon, 2015. "Willingness to pay for telecare programmes to support independent living: Results from a contingent valuation study," Social Science & Medicine, Elsevier, vol. 124(C), pages 94-102.
  198. Aakvik, Arild & Holmås, Tor Helge & Kjerstad, Egil, 2015. "Prioritization and the elusive effect on welfare – A Norwegian health care reform revisited," Social Science & Medicine, Elsevier, vol. 128(C), pages 290-300.
  199. Hedwig Blommestein & Margreet Franken & Carin Uyl-de Groot, 2015. "A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry," PharmacoEconomics, Springer, vol. 33(6), pages 551-560, June.
  200. Stéphane Verguet & Jane J. Kim & Dean T. Jamison, 2016. "Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial," PharmacoEconomics, Springer, vol. 34(9), pages 913-923, September.
  201. Yvonne Beaugé & Jean-Louis Koulidiati & Valéry Ridde & Paul Jacob Robyn & Manuela De Allegri, 2018. "How much does community-based targeting of the ultra-poor in the health sector cost? Novel evidence from Burkina Faso," Health Economics Review, Springer, vol. 8(1), pages 1-11, December.
  202. Tonei, Valentina, 2019. "Mother’s mental health after childbirth: Does the delivery method matter?," Journal of Health Economics, Elsevier, vol. 63(C), pages 182-196.
  203. Hareth Al-Janabi & Job van Exel & Werner Brouwer & Joanna Coast, 2016. "A Framework for Including Family Health Spillovers in Economic Evaluation," Medical Decision Making, , vol. 36(2), pages 176-186, February.
  204. Robin de Vries & Mirjam Kretzschmar & Joop F P Schellekens & Florens G A Versteegh & Tjalke A Westra & John J Roord & Maarten J Postma, 2010. "Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands: Using an Individual-Based Dynamic Model," PLOS ONE, Public Library of Science, vol. 5(10), pages 1-11, October.
  205. Fan Yang & Colin Angus & Ana Duarte & Duncan Gillespie & Mark Sculpher & Simon Walker & Susan Griffin, 2021. "Comparing smoking cessation to screening and brief intervention for alcohol in distributional cost effectiveness analysis to explore the sensitivity of results to socioeconomic inequalities characteri," Working Papers 184cherp, Centre for Health Economics, University of York.
  206. Marieke Krol & Jocé Papenburg & Job van Exel, 2015. "Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies," PharmacoEconomics, Springer, vol. 33(2), pages 123-135, February.
  207. MORENO-TERNERO, Juan & OSTERDAL, Lars P., 2014. "Normative foundations for equity-sensitive population health evaluation functions," LIDAM Discussion Papers CORE 2014031, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
  208. Forder, Julien E. & Caiels, James, 2011. "Measuring the outcomes of long-term care," Social Science & Medicine, Elsevier, vol. 73(12), pages 1766-1774.
  209. Claire McKenna & Karl Claxton, 2011. "Addressing Adoption and Research Design Decisions Simultaneously," Medical Decision Making, , vol. 31(6), pages 853-865, November.
  210. Chantal Guilhaume & Delphine Saragoussi & John Cochran & Clément François & Mondher Toumi, 2010. "Modeling stroke management: a qualitative review of cost-effectiveness analyses," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 11(4), pages 419-426, August.
  211. Simon J Palfreyman & Phil Shackley & John E Brazier, 2010. "Assessing current health‐related quality of life questionnaires administered to patients with venous ulcers: can they be used in economic evaluations?," Journal of Clinical Nursing, John Wiley & Sons, vol. 19(5‐6), pages 892-897, March.
  212. Kelly, Michael & Morgan, Antony & Ellis, Simon & Younger, Tricia & Huntley, Jane & Swann, Catherine, 2010. "Evidence based public health: A review of the experience of the National Institute of Health and Clinical Excellence (NICE) of developing public health guidance in England," Social Science & Medicine, Elsevier, vol. 71(6), pages 1056-1062, September.
  213. Abdur Razzaque Sarker & Marufa Sultana, 2020. "Cost-effective analysis of childhood malaria vaccination in endemic hotspots of Bangladesh," PLOS ONE, Public Library of Science, vol. 15(5), pages 1-15, May.
  214. Theresa Tawiah & Kristian Schultz Hansen & Frank Baiden & Jane Bruce & Mathilda Tivura & Rupert Delimini & Seeba Amengo-Etego & Daniel Chandramohan & Seth Owusu-Agyei & Jayne Webster, 2016. "Cost-Effectiveness Analysis of Test-Based versus Presumptive Treatment of Uncomplicated Malaria in Children under Five Years in an Area of High Transmission in Central Ghana," PLOS ONE, Public Library of Science, vol. 11(10), pages 1-18, October.
  215. Aris Angelis & Panos Kanavos, 2016. "Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment," PharmacoEconomics, Springer, vol. 34(5), pages 435-446, May.
  216. María Buti & Itziar Oyagüez & Virginia Lozano & Miguel Casado, 2013. "Cost Effectiveness of First-Line Oral Antiviral Therapies for Chronic Hepatitis B," PharmacoEconomics, Springer, vol. 31(1), pages 63-75, January.
  217. Jan-Willem H Dik & Ron Hendrix & Alex W Friedrich & Jos Luttjeboer & Prashant Nannan Panday & Kasper R Wilting & Jerome R Lo-Ten-Foe & Maarten J Postma & Bhanu Sinha, 2015. "Cost-Minimization Model of a Multidisciplinary Antibiotic Stewardship Team Based on a Successful Implementation on a Urology Ward of an Academic Hospital," PLOS ONE, Public Library of Science, vol. 10(5), pages 1-12, May.
  218. Ken Buckingham & Nancy Devlin, 2006. "A theoretical framework for TTO valuations of health," Health Economics, John Wiley & Sons, Ltd., vol. 15(10), pages 1149-1154, October.
  219. Abimbola O Famuyide & Shannon K Laughlin-Tommaso & Sherif A Shazly & Kirsten Hall Long & Daniel M Breitkopf & Amy L Weaver & Michaela E McGree & Sherif A El-Nashar & Maureen A Lemens & Matthew R Hopki, 2017. "Medical therapy versus radiofrequency endometrial ablation in the initial treatment of heavy menstrual bleeding (iTOM Trial): A clinical and economic analysis," PLOS ONE, Public Library of Science, vol. 12(11), pages 1-15, November.
  220. Chantelle Murley & Petter Tinghög & Kristina Alexanderson & Jan Hillert & Emilie Friberg & Korinna Karampampa, 2021. "Cost-of-Illness Progression Before and After Diagnosis of Multiple Sclerosis: A Nationwide Register-Based Cohort Study in Sweden of People Newly Diagnosed with Multiple Sclerosis and a Population-Base," PharmacoEconomics, Springer, vol. 39(7), pages 835-851, July.
  221. Simon Eckermann & Tim Coelli, 2008. "Including quality attributes in a model of health care efficiency: A net benefit approach," CEPA Working Papers Series WP032008, School of Economics, University of Queensland, Australia.
  222. Don Husereau & Michael Drummond & Stavros Petrou & Chris Carswell & David Moher & Dan Greenberg & Federico Augustovski & Andrew Briggs & Josephine Mauskopf & Elizabeth Loder, 2013. "Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(3), pages 367-372, June.
  223. Battistoni, Giuseppe & Genco, Mario & Marsilio, Marta & Pancotti, Chiara & Rossi, Sandro & Vignetti, Silvia, 2016. "Cost–benefit analysis of applied research infrastructure. Evidence from health care," Technological Forecasting and Social Change, Elsevier, vol. 112(C), pages 79-91.
  224. Bradley Chen & Victoria Y. Fan, 2015. "Strategic Provider Behavior Under Global Budget Payment with Price Adjustment in Taiwan," Health Economics, John Wiley & Sons, Ltd., vol. 24(11), pages 1422-1436, November.
  225. Simon Eckermann & Brita Pekarsky, 2014. "Can the Real Opportunity Cost Stand Up: Displaced Services, the Straw Man Outside the Room," PharmacoEconomics, Springer, vol. 32(4), pages 319-325, April.
  226. Janneke Grutters & Mark Sculpher & Andrew Briggs & Johan Severens & Math Candel & James Stahl & Dirk Ruysscher & Albert Boer & Bram Ramaekers & Manuela Joore, 2013. "Acknowledging Patient Heterogeneity in Economic Evaluation," PharmacoEconomics, Springer, vol. 31(2), pages 111-123, February.
  227. Francisco Jódar-Sánchez & Amaia Malet-Larrea & José Martín & Leticia García-Mochón & M. López del Amo & Fernando Martínez-Martínez & Miguel Gastelurrutia-Garralda & Victoria García-Cárdenas & Daniel S, 2015. "Cost-Utility Analysis of a Medication Review with Follow-Up Service for Older Adults with Polypharmacy in Community Pharmacies in Spain: The conSIGUE Program," PharmacoEconomics, Springer, vol. 33(6), pages 599-610, June.
  228. Ava A John-Baptiste & Wei Wu & Paula Rochon & Geoffrey M Anderson & Chaim M Bell, 2013. "A Systematic Review and Methodological Evaluation of Published Cost-Effectiveness Analyses of Aromatase Inhibitors versus Tamoxifen in Early Stage Breast Cancer," PLOS ONE, Public Library of Science, vol. 8(5), pages 1-9, May.
  229. Saha, Sanjib & Gerdtham, Ulf-G. & Toresson, Håkan & Minthon, Lennart & Jarl, Johan, 2018. "Economic Evaluation of Nonpharmacological Interventions for Dementia Patients and their Caregivers - A Systematic Literature Review," Working Papers 2018:10, Lund University, Department of Economics.
  230. Tangka, Florence K.L. & Subramanian, Sujha & Hoover, Sonja & Royalty, Janet & Joseph, Kristy & DeGroff, Amy & Joseph, Djenaba & Chattopadhyay, Sajal, 2017. "Costs of promoting cancer screening: Evidence from CDC’s Colorectal Cancer Control Program (CRCCP)," Evaluation and Program Planning, Elsevier, vol. 62(C), pages 67-72.
  231. Theodoros Mantopoulos & Paul M. Mitchell & Nicky J. Welton & Richard McManus & Lazaros Andronis, 2016. "Choice of statistical model for cost-effectiveness analysis and covariate adjustment: empirical application of prominent models and assessment of their results," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(8), pages 927-938, November.
  232. Maria Gheorghe & Renske J. Hoefman & Matthijs M. Versteegh & Job Exel, 2019. "Estimating Informal Caregiving Time from Patient EQ-5D Data: The Informal CARE Effect (iCARE) Tool," PharmacoEconomics, Springer, vol. 37(1), pages 93-103, January.
  233. Chiranjeev Sanyal & Paul Stolee & Don Juzwishin & Don Husereau, 2018. "Economic evaluations of eHealth technologies: A systematic review," PLOS ONE, Public Library of Science, vol. 13(6), pages 1-11, June.
  234. Ana Babac & Kathrin Damm & J.-Matthias Schulenburg, 2019. "Patient-reported data informing early benefit assessment of rare diseases in Germany: A systematic review," Health Economics Review, Springer, vol. 9(1), pages 1-17, December.
  235. Zou, Guang Yong & Taleban, Julia & Huo, Cindy Y., 2009. "Confidence interval estimation for lognormal data with application to health economics," Computational Statistics & Data Analysis, Elsevier, vol. 53(11), pages 3755-3764, September.
  236. Zeynep Or & Thomas Renaud, 2009. "Activity based payment in hospitals: Principles and issues drawn from the economic literature and country experiences," Working Papers DT23, IRDES institut for research and information in health economics, revised Mar 2009.
  237. Tristan Snowsill, 2019. "A New Method for Model-Based Health Economic Evaluation Utilizing and Extending Moment-Generating Functions," Medical Decision Making, , vol. 39(5), pages 523-539, July.
  238. Aidan R. Vining & David L. Weimer, 2013. "An assessment of important issues concerning the application of benefit–cost analysis to social policy," Chapters, in: Scott O. Farrow & Richard Zerbe, Jr. (ed.), Principles and Standards for Benefit–Cost Analysis, chapter 1, pages 25-62, Edward Elgar Publishing.
  239. Manuel Arias & Francisco Díez, 2014. "The Problem of Embedded Decision Nodes in Cost-Effectiveness Decision Trees," PharmacoEconomics, Springer, vol. 32(11), pages 1141-1145, November.
  240. Bruce Larson & Kathryn Schnippel & Buyiswa Ndibongo & Lawrence Long & Matthew P Fox & Sydney Rosen, 2012. "How to Estimate the Cost of Point-of-Care CD4 Testing in Program Settings: An Example Using the Alere Pima™ Analyzer in South Africa," PLOS ONE, Public Library of Science, vol. 7(4), pages 1-8, April.
  241. Gemma Shields & Stephen Beard, 2015. "A Systematic Review of the Economic and Humanistic Burden of Gout," PharmacoEconomics, Springer, vol. 33(10), pages 1029-1047, October.
  242. Hareth Al‐Janabi & Job Van Exel & Werner Brouwer & Caroline Trotter & Linda Glennie & Laurie Hannigan & Joanna Coast, 2016. "Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis," Health Economics, John Wiley & Sons, Ltd., vol. 25(12), pages 1529-1544, December.
  243. G. Ramos & Antoinette Asselt & Sandra Kuiper & Johan Severens & Tanja Maas & Edward Dompeling & J. Knottnerus & Onno Schayck, 2014. "Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(8), pages 869-883, November.
  244. Fenna Arnoldussen & Mark J. Koetse & Sander M. de Bruyn & Onno Kuik, 2022. "What Are People Willing to Pay for Social Sustainability? A Choice Experiment among Dutch Consumers," Sustainability, MDPI, vol. 14(21), pages 1-21, November.
  245. Oscar Andrés Espinosa Acuna, 2020. "Clasificación de estados de salud y metodologías de valoración de preferencias para el cálculo de AVAC: una revisión de literatura," Ensayos de Economía 19137, Universidad Nacional de Colombia Sede Medellín.
  246. Catherine Henderson & Martin Knapp & Ksenija Yeeles & Stephen Bremner & Sandra Eldridge & Anthony S David & Nicola O’Connell & Tom Burns & Stefan Priebe, 2015. "Cost-Effectiveness of Financial Incentives to Promote Adherence to Depot Antipsychotic Medication: Economic Evaluation of a Cluster-Randomised Controlled Trial," PLOS ONE, Public Library of Science, vol. 10(10), pages 1-18, October.
  247. Yllka Kodra & Marianna Cavazza & Marta de Santis & Andrea Guala & Maria-Elena Liverani & Patrizio Armeni & Maura Masini & Domenica Taruscio, 2020. "Social Economic Costs, Health-Related Quality of Life and Disability in Patients with Cri Du Chat Syndrome," IJERPH, MDPI, vol. 17(16), pages 1-14, August.
  248. Ulla Kou Griffiths & Rosa Legood & Catherine Pitt, 2016. "Comparison of Economic Evaluation Methods Across Low‐income, Middle‐income and High‐income Countries: What are the Differences and Why?," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 29-41, February.
  249. Luyten, Jeroen & Beutels, Philippe & Vandermeulen, Corinne & Kessels, Roselinde, 2022. "Social preferences for adopting new vaccines in the national immunization program: A discrete choice experiment," Social Science & Medicine, Elsevier, vol. 303(C).
  250. Gregoire Mercier & Gerald Naro, 2014. "Costing Hospital Surgery Services: The Method Matters," PLOS ONE, Public Library of Science, vol. 9(5), pages 1-7, May.
  251. Kai Huter & Tobias Krick & Heinz Rothgang, 2022. "Health economic evaluation of digital nursing technologies: a review of methodological recommendations," Health Economics Review, Springer, vol. 12(1), pages 1-13, December.
  252. Boone, J., 2014. "Basic versus Supplementary Health Insurance : The Role of Cost Effectiveness and Prevalence," Other publications TiSEM be4cbf5b-f13b-460a-a9cc-1, Tilburg University, School of Economics and Management.
  253. Nikki McCaffrey & Meera Agar & Janeane Harlum & Jonathon Karnon & David Currow & Simon Eckermann, 2015. "Better Informing Decision Making with Multiple Outcomes Cost-Effectiveness Analysis under Uncertainty in Cost-Disutility Space," PLOS ONE, Public Library of Science, vol. 10(3), pages 1-19, March.
  254. Jesse Elliott & Sasha Katwyk & Bláthnaid McCoy & Tammy Clifford & Beth K. Potter & Becky Skidmore & George A. Wells & Doug Coyle, 2019. "Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations," PharmacoEconomics, Springer, vol. 37(10), pages 1261-1276, October.
  255. Magnus Johannesson;Bengt Jonsson;Linus Jonsson;Gisela Kobelt;Niklas Zethraeus, 2009. "Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?," Briefing 000228, Office of Health Economics.
  256. McTaggart-Cowan, Helen & Tsuchiya, Aki & O'Cathain, Alicia & Brazier, John, 2011. "Understanding the effect of disease adaptation information on general population values for hypothetical health states," Social Science & Medicine, Elsevier, vol. 72(11), pages 1904-1912, June.
  257. Paul F M Krabbe, 2013. "A Generalized Measurement Model to Quantify Health: The Multi-Attribute Preference Response Model," PLOS ONE, Public Library of Science, vol. 8(11), pages 1-12, November.
  258. repec:bla:glopol:v:8:y:2017:i::p:46-59 is not listed on IDEAS
  259. Wei Zhang & Aslam Anis, 2014. "Health-Related Productivity Loss: NICE to Recognize Soon, Good to Discuss Now," PharmacoEconomics, Springer, vol. 32(5), pages 425-427, May.
  260. Sennen Hounton & David Newlands, 2012. "Applying the Net-Benefit Framework for Analyzing and Presenting Cost-Effectiveness Analysis of a Maternal and Newborn Health Intervention," PLOS ONE, Public Library of Science, vol. 7(7), pages 1-8, July.
  261. Wilke, Tilman & Belaya, Vera & Pinior, Beate, 2012. "How to Measure Food Safety? A Review of Relevant Literature," 2012 International European Forum, February 13-17, 2012, Innsbruck-Igls, Austria 144947, International European Forum on System Dynamics and Innovation in Food Networks.
  262. Denise Howel & Suzanne Moffatt & Catherine Haighton & Andrew Bryant & Frauke Becker & Melanie Steer & Sarah Lawson & Terry Aspray & Eugene M G Milne & Luke Vale & Elaine McColl & Martin White, 2019. "Does domiciliary welfare rights advice improve health-related quality of life in independent-living, socio-economically disadvantaged people aged ≥60 years? Randomised controlled trial, economic and p," PLOS ONE, Public Library of Science, vol. 14(1), pages 1-31, January.
  263. Mahdi Gharaibeh & J. Lyle Bootman & Ali McBride & Jennifer Martin & Ivo Abraham, 2017. "Economic Evaluations of First-Line Chemotherapy Regimens for Pancreatic Cancer: A Critical Review," PharmacoEconomics, Springer, vol. 35(1), pages 83-95, January.
  264. Juliet N Sekandi & Kevin Dobbin & James Oloya & Alphonse Okwera & Christopher C Whalen & Phaedra S Corso, 2015. "Cost-Effectiveness Analysis of Community Active Case Finding and Household Contact Investigation for Tuberculosis Case Detection in Urban Africa," PLOS ONE, Public Library of Science, vol. 10(2), pages 1-18, February.
  265. Fabienne Abadie & Christian Boehler & Maria Lluch & Ramon Sabes-Figuera, 2014. "Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing (MAFEIP) First report on outcome indicators," JRC Research Reports JRC91162, Joint Research Centre.
  266. Simon, Judit & Anand, Paul & Gray, Alastair & Rugkåsa, Jorun & Yeeles, Ksenija & Burns, Tom, 2013. "Operationalising the capability approach for outcome measurement in mental health research," Social Science & Medicine, Elsevier, vol. 98(C), pages 187-196.
  267. Gillian R. Currie & Brittany Gerber & Diane Lorenzetti & Karen MacDonald & Susanne M. Benseler & Francois P. Bernier & Kym M. Boycott & K. Vanessa Carias & Bettina Hamelin & Robin Z. Hayeems & Claire , 2023. "Developing a Framework of Cost Elements of Socioeconomic Burden of Rare Disease: A Scoping Review," PharmacoEconomics, Springer, vol. 41(7), pages 803-818, July.
  268. Sanjib Saha & Birgitta Grahn & Ulf-G. Gerdtham & Kjerstin Stigmar & Sara Holmberg & Johan Jarl, 2019. "Structured physiotherapy including a work place intervention for patients with neck and/or back pain in primary care: an economic evaluation," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(2), pages 317-327, March.
  269. Nancy J. Devlin & Aki Tsuchiya & Ken Buckingham & Carl Tilling, 2011. "A uniform time trade off method for states better and worse than dead: feasibility study of the ‘lead time’ approach," Health Economics, John Wiley & Sons, Ltd., vol. 20(3), pages 348-361, March.
  270. Patrick J. McEwan, 2012. "Cost-effectiveness analysis of education and health interventions in developing countries," Journal of Development Effectiveness, Taylor & Francis Journals, vol. 4(2), pages 189-213, June.
  271. Marlon Mundt & Larissa Zakletskaia, 2014. "That’s What Friends Are For: Adolescent Peer Social Status, Health-Related Quality of Life and Healthcare Costs," Applied Health Economics and Health Policy, Springer, vol. 12(2), pages 191-201, April.
  272. Sangeeta Budhia & Yeshi Mikyas & Michael Tang & Enkhe Badamgarav, 2012. "Osteoporotic Fractures," PharmacoEconomics, Springer, vol. 30(2), pages 147-170, February.
  273. Susanne Mayer & Noemi Kiss & Agata Łaszewska & Judit Simon, 2017. "Costing evidence for health care decision-making in Austria: A systematic review," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-18, August.
  274. Yoko Laurence & Ulla Griffiths & Anna Vassall, 2015. "Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review," PharmacoEconomics, Springer, vol. 33(9), pages 939-955, September.
  275. Adam J. N. Raymakers & John Mayo & Stephen Lam & J. Mark FitzGerald & David G. T. Whitehurst & Larry D. Lynd, 2016. "Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review," Applied Health Economics and Health Policy, Springer, vol. 14(4), pages 409-418, August.
  276. Martin Emmert & Frank Eijkenaar & Heike Kemter & Adelheid Esslinger & Oliver Schöffski, 2012. "Economic evaluation of pay-for-performance in health care: a systematic review," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(6), pages 755-767, December.
  277. Hazel Squires & James Chilcott & Ronald Akehurst & Jennifer Burr & Michael P. Kelly, 2016. "A systematic literature review of the key challenges for developing the structure of public health economic models," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 61(3), pages 289-298, April.
  278. Laura Bojke & Andrea Manca & Miqdad Asaria & Ronan Mahon & Shijie Ren & Stephen Palmer, 2017. "How to Appropriately Extrapolate Costs and Utilities in Cost-Effectiveness Analysis," PharmacoEconomics, Springer, vol. 35(8), pages 767-776, August.
  279. Betty Tao & Massimo Pietropaolo & Mark Atkinson & Desmond Schatz & David Taylor, 2010. "Estimating the Cost of Type 1 Diabetes in the U.S.: A Propensity Score Matching Method," PLOS ONE, Public Library of Science, vol. 5(7), pages 1-11, July.
  280. Rogowski, Wolf, 2007. "Current impact of gene technology on healthcare: A map of economic assessments," Health Policy, Elsevier, vol. 80(2), pages 340-357, February.
  281. Rachel Meacock & Nicola Dale & Mark Harrison, 2013. "The Humanistic and Economic Burden of Systemic Lupus Erythematosus," PharmacoEconomics, Springer, vol. 31(1), pages 49-61, January.
  282. Andrew J Sutton & Katie Breheny & Jon Deeks & Kamlesh Khunti & Claire Sharpe & Ryan S Ottridge & Paul E Stevens & Paul Cockwell & Philp A Kalra & Edmund J Lamb & eGFR-C study group, 2015. "Methods Used in Economic Evaluations of Chronic Kidney Disease Testing — A Systematic Review," PLOS ONE, Public Library of Science, vol. 10(10), pages 1-16, October.
  283. Jens Leth Hougaard & Juan D. Moreno-Ternero & Lars Peter Østerdal, 2013. "On the Measurement of the (Multidimensional) Inequality of Health Distributions," Research on Economic Inequality, in: Health and Inequality, volume 21, pages 111-129, Emerald Group Publishing Limited.
  284. Marie-Odile Carrère & Yves Devaux & Nathalie Havet & Magali Morelle & Raphaël Remonnay & Valérie Kante, 2008. "Administration des transfusions sanguines à l'hôpital ou à domicile ? Le choix des patients atteints de cancer," Post-Print halshs-00353328, HAL.
  285. Rilana Prenger & Marcel Pieterse & Louise Braakman-Jansen & Job Palen & Lieke Christenhusz & Erwin Seydel, 2013. "Moving beyond a limited follow-up in cost-effectiveness analyses of behavioral interventions," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(2), pages 297-306, April.
  286. Nicola E Stanczyk & Eline S Smit & Daniela N Schulz & Hein de Vries & Catherine Bolman & Jean W M Muris & Silvia M A A Evers, 2014. "An Economic Evaluation of a Video- and Text-Based Computer-Tailored Intervention for Smoking Cessation: A Cost-Effectiveness and Cost-Utility Analysis of a Randomized Controlled Trial," PLOS ONE, Public Library of Science, vol. 9(10), pages 1-14, October.
  287. Tryphine Zulu & Marion Heap & Edina Sinanovic, 2017. "The cost and utilisation patterns of a pilot sign language interpreter service for primary health care services in South Africa," PLOS ONE, Public Library of Science, vol. 12(12), pages 1-11, December.
  288. Boone, J., 2014. "Basic Versus Supplementary Health Insurance : Moral Hazard and Adverse Selection," Other publications TiSEM 8ad45428-2ab4-406f-bbd3-3, Tilburg University, School of Economics and Management.
  289. Yoel Lubell & Anne J Mills & Christopher J M Whitty & Sarah G Staedke, 2010. "An Economic Evaluation of Home Management of Malaria in Uganda: An Interactive Markov Model," PLOS ONE, Public Library of Science, vol. 5(8), pages 1-10, August.
  290. Rachael Hunter & Gianluca Baio & Thomas Butt & Stephen Morris & Jeff Round & Nick Freemantle, 2015. "An Educational Review of the Statistical Issues in Analysing Utility Data for Cost-Utility Analysis," PharmacoEconomics, Springer, vol. 33(4), pages 355-366, April.
  291. Marilys Victoire Razakamanana & Martine Audibert & Tantely Andrianantoandro & Aina Harimanana, 2017. "Impact and Efficiency of the Integration of Diagnosis and Treatment of Pneumonia in Malaria Community Case Management in Madagascar," Working Papers halshs-01479210, HAL.
  292. Oriana Ciani & Britni Wilcher & Anoukh van Giessen & Rod S. Taylor, 2017. "Linking the Regulatory and Reimbursement Processes for Medical Devices: The Need for Integrated Assessments," Health Economics, John Wiley & Sons, Ltd., vol. 26(S1), pages 13-29, February.
  293. Peter C. Smith, 2013. "Incorporating Financial Protection Into Decision Rules For Publicly Financed Healthcare Treatments," Health Economics, John Wiley & Sons, Ltd., vol. 22(2), pages 180-193, February.
  294. Emelie Heintz & Andreas Gerber-Grote & Salah Ghabri & Francoise F. Hamers & Valentina Prevolnik Rupel & Renata Slabe-Erker & Thomas Davidson, 2016. "Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries," PharmacoEconomics, Springer, vol. 34(1), pages 59-76, January.
  295. Eyjolfur Sigurdsson & Kristin Siggeirsdottir & Halldor Jonsson & Vilmundur Gudnason & Thorolfur Matthiasson & Brynjolfur Jonsson, 2008. "Early discharge and home intervention reduces unit costs after total hip replacement: results of a cost analysis in a randomized study," International Journal of Health Economics and Management, Springer, vol. 8(3), pages 181-192, September.
  296. Juan D. Moreno-Ternero & Lars Peter Østerdal, 2017. "A normative foundation for equity-sensitive health evaluation: The role of relative comparisons of health gains," Journal of Public Economic Theory, Association for Public Economic Theory, vol. 19(5), pages 1009-1025, October.
  297. Maxwell Ayindenaba Dalaba & Patricia Akweongo & Raymond Akawire Aborigo & Happiness Pius Saronga & John Williams & Antje Blank & Jens Kaltschmidt & Rainer Sauerborn & Svetla Loukanova, 2015. "Cost-Effectiveness of Clinical Decision Support System in Improving Maternal Health Care in Ghana," PLOS ONE, Public Library of Science, vol. 10(5), pages 1-12, May.
  298. Emmanouil Mentzakis & Mandy Ryan & Paul McNamee, 2011. "Using discrete choice experiments to value informal care tasks: exploring preference heterogeneity," Health Economics, John Wiley & Sons, Ltd., vol. 20(8), pages 930-944, August.
  299. Laura Vallejo-Torres, 2023. "The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework," Applied Health Economics and Health Policy, Springer, vol. 21(3), pages 373-384, May.
  300. Hassan Serrier & Hélène Sultan-Taieb & Danièle Luce & Sophie Bejean, 2014. "Estimating the social cost of respiratory cancer cases attributable to occupational exposures in France," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(6), pages 661-673, July.
  301. Julie A. Campbell & Andrew J. Palmer & Alison Venn & Melanie Sharman & Petr Otahal & Amanda Neil, 2016. "A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D Multi-Attribute Utility Instruments in Patients Who Have Previously Undergone Bariatric Surgery," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 9(4), pages 311-322, August.
  302. R. Hernández & D. Jenkinson & L. Vale & B. Cuthbertson, 2014. "Economic evaluation of nurse-led intensive care follow-up programmes compared with standard care: the PRaCTICaL trial," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(3), pages 243-252, April.
  303. Johns, Benjamin & Probandari, Ari & Mahendradhata, Yodi & Ahmad, Riris Andono, 2009. "An analysis of the costs and treatment success of collaborative arrangements among public and private providers for tuberculosis control in Indonesia," Health Policy, Elsevier, vol. 93(2-3), pages 214-224, December.
  304. Edward Wilson, 2010. "Cost Effectiveness of Imiquimod 5% Cream Compared with Methyl Aminolevulinate-Based Photodynamic Therapy in the Treatment of Non-Hyperkeratotic, Non-Hypertrophic Actinic (Solar) Keratoses A Decision T," PharmacoEconomics, Springer, vol. 28(11), pages 1055-1064, November.
  305. Adam Martin & Alex Jones & Miranda Mugford & Ian Shemilt & Ruth Hancock & Raphael Wittenberg, 2012. "Methods Used To Identify And Measure Resource Use In Economic Evaluations: A Systematic Review Of Questionnaires For Older People," Health Economics, John Wiley & Sons, Ltd., vol. 21(8), pages 1017-1022, August.
  306. Jonas Steel & Lode Godderis & Jeroen Luyten, 2018. "Methodological Challenges in the Economic Evaluation of Occupational Health and Safety Programmes," IJERPH, MDPI, vol. 15(11), pages 1-12, November.
  307. Markiewicz, Katarzyna & van Til, Janine A. & Steuten, Lotte M.G. & IJzerman, Maarten J., 2016. "Commercial viability of medical devices using Headroom and return on investment calculation," Technological Forecasting and Social Change, Elsevier, vol. 112(C), pages 338-346.
  308. Magnus Zingmark & Fredrik Norström & Lars Lindholm & Synneve Dahlin-Ivanoff & Susanne Gustafsson, 2019. "Modelling long-term cost-effectiveness of health promotion for community-dwelling older people," European Journal of Ageing, Springer, vol. 16(4), pages 395-404, December.
  309. Takeru Shiroiwa & Yoon‐Kyoung Sung & Takashi Fukuda & Hui‐Chu Lang & Sang‐Cheol Bae & Kiichiro Tsutani, 2010. "International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?," Health Economics, John Wiley & Sons, Ltd., vol. 19(4), pages 422-437, April.
  310. Michela Tinelli & Mandy Ryan & Christine Bond, 2016. "What, who and when? Incorporating a discrete choice experiment into an economic evaluation," Health Economics Review, Springer, vol. 6(1), pages 1-9, December.
  311. Jen Kruger & Alan Brennan, 2013. "The cost of Type 1 diabetes mellitus in the United Kingdom: a review of cost-of-illness studies," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(6), pages 887-899, December.
  312. Fuhmei Wang & Jung-Der Wang, 2017. "Telehealth and Sustainable Improvements to Quality of Life," Applied Research in Quality of Life, Springer;International Society for Quality-of-Life Studies, vol. 12(1), pages 173-184, March.
  313. Nadia Yakhelef & Martine Audibert & Francis Varaine & Jeremiah Chakaya & Joseph Sitienei & Helena Huerga & Marilyne Bonnet, 2013. "Is introducing rapid culture in the diagnostic algorithm of smear-negative tuberculosis cost-effective?," Working Papers halshs-00866530, HAL.
  314. Sabina Sanghera & Emma Frew & Janesh Gupta & Joe Kai & Tracy Roberts, 2015. "Exploring the Use of Cost-Benefit Analysis to Compare Pharmaceutical Treatments for Menorrhagia," PharmacoEconomics, Springer, vol. 33(9), pages 957-965, September.
  315. M. Azhar Hussain & Mette Møller Jørgensen & Lars Peter Østerdal, 2016. "Refining Population Health Comparisons: A Multidimensional First Order Dominance Approach," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 129(2), pages 739-759, November.
  316. Ingrid Zechmeister-Koss & Petra Schnell-Inderst & Günther Zauner, 2014. "Appropriate Evidence Sources for Populating Decision Analytic Models within Health Technology Assessment (HTA)," Medical Decision Making, , vol. 34(3), pages 288-299, April.
  317. Kittiphong Thiboonboon & Pattara Leelahavarong & Duangrurdee Wattanasirichaigoon & Nithiwat Vatanavicharn & Pornswan Wasant & Vorasuk Shotelersuk & Suthipong Pangkanon & Chulaluck Kuptanon & Sumonta C, 2015. "An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand," PLOS ONE, Public Library of Science, vol. 10(8), pages 1-25, August.
  318. Bengt Liljas & Göran S. Karlsson & Nils‐Olov Stålhammar, 2008. "On future non‐medical costs in economic evaluations," Health Economics, John Wiley & Sons, Ltd., vol. 17(5), pages 579-591, May.
  319. Paddy Gillespie & Eamon O’Shea & Andrew Murphy & Susan Smith & Mary Byrne & Molly Byrne & Margaret Cupples, 2012. "Relative cost effectiveness of the SPHERE intervention in selected patient subgroups with existing coronary heart disease," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(4), pages 429-443, August.
  320. Wouters, S. & van Exel, N.J.A. & Rohde, K.I.M. & Vromen, J.J. & Brouwer, W.B.F., 2017. "Acceptable health and priority weighting: Discussing a reference-level approach using sufficientarian reasoning," Social Science & Medicine, Elsevier, vol. 181(C), pages 158-167.
  321. Turgay Ayer & Oguzhan Alagoz & Natasha K. Stout & Elizabeth S. Burnside, 2016. "Heterogeneity in Women’s Adherence and Its Role in Optimal Breast Cancer Screening Policies," Management Science, INFORMS, vol. 62(5), pages 1339-1362, May.
  322. Xian Li & Stephen Jan & Lijing L Yan & Alison Hayes & Yunbo Chu & Haijun Wang & Xiangxian Feng & Wenyi Niu & Feng J He & Jun Ma & Yanbo Han & Graham A MacGregor & Yangfeng Wu, 2017. "Cost and cost-effectiveness of a school-based education program to reduce salt intake in children and their families in China," PLOS ONE, Public Library of Science, vol. 12(9), pages 1-17, September.
  323. Ian M. McCarthy, 2015. "Putting the Patient in Patient Reported Outcomes: A Robust Methodology for Health Outcomes Assessment," Health Economics, John Wiley & Sons, Ltd., vol. 24(12), pages 1588-1603, December.
  324. Manuel A. Espinoza & Andrea Manca & Karl Claxton & Mark J. Sculpher, 2014. "The Value of Heterogeneity for Cost-Effectiveness Subgroup Analysis," Medical Decision Making, , vol. 34(8), pages 951-964, November.
  325. Don Husereau & Michael Drummond & Stavros Petrou & Dan Greenberg & Josephine Mauskopf & Federico Augustovski & Andrew Briggs & David Moher & Elizabeth Loder & Chris Carswell, 2015. "Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration," PharmacoEconomics, Springer, vol. 33(5), pages 535-536, May.
  326. Vakaramoko Diaby & Jean Lachaine, 2011. "An application of a proposed framework for formulary listing in low-income countries," Applied Health Economics and Health Policy, Springer, vol. 9(6), pages 389-402, November.
  327. Lauren E. Cipriano & Thomas A. Weber, 2018. "Population-level intervention and information collection in dynamic healthcare policy," Health Care Management Science, Springer, vol. 21(4), pages 604-631, December.
  328. Peter Makai & Willemijn Looman & Eddy Adang & René Melis & Elly Stolk & Isabelle Fabbricotti, 2015. "Cost-effectiveness of integrated care in frail elderly using the ICECAP-O and EQ-5D: does choice of instrument matter?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(4), pages 437-450, May.
  329. Nora Döring & Susanne Mayer & Finn Rasmussen & Diana Sonntag, 2016. "Economic Evaluation of Obesity Prevention in Early Childhood: Methods, Limitations and Recommendations," IJERPH, MDPI, vol. 13(9), pages 1-11, September.
  330. May, Uwe & Bauer, Cosima & Wasem, Jürgen, 2014. "Gesundheitsökonomie einer Packungsgrößenbeschränkung: Gutachten im Auftrag der Johnson & Johnson GmbH," IBES Diskussionsbeiträge 203, University of Duisburg-Essen, Institute of Business and Economic Studie (IBES).
  331. Kyung Suk Lee & Ye-Rin Lee & So-Youn Park & In-Hwan Oh, 2018. "The economic burden of rotavirus infection in South Korea from 2009 to 2012," PLOS ONE, Public Library of Science, vol. 13(3), pages 1-11, March.
  332. Petter Viksveen & Zofia Dymitr & Steven Simoens, 2014. "Economic evaluations of homeopathy: a review," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(2), pages 157-174, March.
  333. Christian Schaetti & Mitchell G Weiss & Said M Ali & Claire-Lise Chaignat & Ahmed M Khatib & Rita Reyburn & Radboud J Duintjer Tebbens & Raymond Hutubessy, 2012. "Costs of Illness Due to Cholera, Costs of Immunization and Cost-Effectiveness of an Oral Cholera Mass Vaccination Campaign in Zanzibar," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 6(10), pages 1-10, October.
  334. Ciani, Oriana & Tarricone, Rosanna & Torbica, Aleksandra, 2012. "Diffusion and use of health technology assessment in policy making: What lessons for decentralised healthcare systems?," Health Policy, Elsevier, vol. 108(2), pages 194-202.
  335. Buckingham, Ken J. & Devlin, Nancy Joy, 2009. "A note on the nature of utility in time and health and implications for cost utility analysis," Social Science & Medicine, Elsevier, vol. 68(2), pages 362-367, January.
  336. Saara Huoponen & Marja Blom, 2015. "A Systematic Review of the Cost-Effectiveness of Biologics for the Treatment of Inflammatory Bowel Diseases," PLOS ONE, Public Library of Science, vol. 10(12), pages 1-23, December.
  337. David Meads & Andrea Marshall & Claire Hulme & Janet Dunn & Hugo Ford, 2016. "The Cost Effectiveness of Docetaxel and Active Symptom Control versus Active Symptom Control Alone for Refractory Oesophagogastric Adenocarcinoma: Economic Analysis of the COUGAR-02 Trial," PharmacoEconomics, Springer, vol. 34(1), pages 33-42, January.
  338. Lavanya Diwakar & Rachel K Morris & Pelham Barton & Lee J Middleton & Mark D Kilby & Tracy E Roberts, 2013. "Evaluation of the Cost Effectiveness of Vesico-Amniotic Shunting in the Management of Congenital Lower Urinary Tract Obstruction (Based on Data from the PLUTO Trial)," PLOS ONE, Public Library of Science, vol. 8(12), pages 1-10, December.
  339. Lawrence Mwenge & Linda Sande & Collin Mangenah & Nurilign Ahmed & Sarah Kanema & Marc d’Elbée & Euphemia Sibanda & Thokozani Kalua & Gertrude Ncube & Cheryl C Johnson & Karin Hatzold & Frances M Cowa, 2017. "Costs of facility-based HIV testing in Malawi, Zambia and Zimbabwe," PLOS ONE, Public Library of Science, vol. 12(10), pages 1-16, October.
  340. Simon Walker & Mark Sculpher & Karl Claxton & Steve Palmer, 2012. "Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions," Working Papers 077cherp, Centre for Health Economics, University of York.
  341. Michal Witkowski & Søren Ilsøe Moreno & João Fernandes & Pierre Johansen & Margarida Augusto & Sunita Nair, 2022. "The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review," PharmacoEconomics, Springer, vol. 40(8), pages 751-776, August.
  342. Christine Godfrey, 2006. "Evidence-Based Illicit Drug Policy: The Potential Contribution of Economic Evaluation Techniques," De Economist, Springer, vol. 154(4), pages 563-580, December.
  343. Rachel Elliott & Helen Weatherly & Neil Hawkins & Gillian Cranny & Duncan Chambers & Lindsey Myers & Alison Eastwood & Mark Sculpher, 2010. "An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 11(1), pages 57-66, February.
  344. Kenneth C. Lichtendahl & Samuel E. Bodily, 2012. "Multiplicative Utilities for Health and Consumption," Decision Analysis, INFORMS, vol. 9(4), pages 314-328, December.
  345. Carmen M Sarabia-Cobo & Paula Parás-Bravo & Francisco José Amo-Setién & Ana Rosa Alconero-Camarero & María Sáenz-Jalón & Blanca Torres-Manrique & Raquel Sarabia-Lavín & Angela Fernández-Rodríguez & Ta, 2017. "Validation of the Spanish Version of the ICECAP-O for Nursing Home Residents with Dementia," PLOS ONE, Public Library of Science, vol. 12(1), pages 1-13, January.
  346. Nicolas Martelli & Capucine Devaux & Hélène van den Brink & Judith Pineau & Patrice Prognon & Isabelle Borget, 2015. "A Systematic Review of the Level of Evidence in Economic Evaluations of Medical Devices: The Example of Vertebroplasty and Kyphoplasty," PLOS ONE, Public Library of Science, vol. 10(12), pages 1-12, December.
  347. Krol, Marieke & Brouwer, Werner, 2015. "Unpaid work in health economic evaluations," Social Science & Medicine, Elsevier, vol. 144(C), pages 127-137.
  348. Roisin Adams & Cathal Walsh & Douglas Veale & Barry Bresnihan & Oliver FitzGerald & Michael Barry, 2010. "Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis," PharmacoEconomics, Springer, vol. 28(6), pages 477-487, June.
  349. Dubeck, Margaret M. & Jukes, Matthew C.H. & Brooker, Simon J. & Drake, Tom L. & Inyega, Hellen N., 2015. "Designing a program of teacher professional development to support beginning reading acquisition in coastal Kenya," International Journal of Educational Development, Elsevier, vol. 41(C), pages 88-96.
  350. Jennifer A. Whitty & Ana Sofia Oliveira Gonçalves, 2018. "A Systematic Review Comparing the Acceptability, Validity and Concordance of Discrete Choice Experiments and Best–Worst Scaling for Eliciting Preferences in Healthcare," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 11(3), pages 301-317, June.
  351. Golan, Ofra & Hansen, Paul & Kaplan, Giora & Tal, Orna, 2011. "Health technology prioritization: Which criteria for prioritizing new technologies and what are their relative weights?," Health Policy, Elsevier, vol. 102(2), pages 126-135.
  352. Saha, Sanjib & Gerdtham, Ulf-G. & Toresson, Håkan & Minthon, Lennart & Jarl, Johan, 2018. "Economic Evaluation of Pharmacological Treatments in Dementia Disorders - A Systematic Literature Review," Working Papers 2018:37, Lund University, Department of Economics.
  353. Mona Aghdaee & Yuanyuan Gu & Kompal Sinha & Bonny Parkinson & Rajan Sharma & Henry Cutler, 2023. "Mapping the Patient-Reported Outcomes Measurement Information System (PROMIS-29) to EQ-5D-5L," PharmacoEconomics, Springer, vol. 41(2), pages 187-198, February.
  354. repec:hal:spmain:info:hdl:2441/3ihldo33ik9ee94procjtfki5f is not listed on IDEAS
  355. Gelli, Aulo & Espejo, Francisco & Shen, Jing & Kristjansson, Elizabeth, 2014. "Putting it all together: Aggregating impacts of school-feeding programmes on education, health and nutrition: Two proposed methodologies," WIDER Working Paper Series 036, World Institute for Development Economic Research (UNU-WIDER).
  356. Govorun, Maria & Latouche, Guy & Loisel, Stéphane, 2015. "Phase-type aging modeling for health dependent costs," Insurance: Mathematics and Economics, Elsevier, vol. 62(C), pages 173-183.
  357. Boone, J., 2013. "Does the Market Choose Optimal Health Insurance Coverage," Other publications TiSEM f7691fbf-f770-4714-b1b4-1, Tilburg University, School of Economics and Management.
  358. Renske Hoefman & Job Exel & Werner Brouwer, 2013. "How to Include Informal Care in Economic Evaluations," PharmacoEconomics, Springer, vol. 31(12), pages 1105-1119, December.
  359. Rowen, D & Brazier, J & Tsuchiya, A & Hernández, M & Ibbotson, R, 2009. "The simultaneous valuation of states from multiple instruments using ranking and VAS data: methods and preliminary results," MPRA Paper 29841, University Library of Munich, Germany.
  360. Nadia Yakhelef & Martine Audibert & Gabriella Ferlazzo & Joseph Sitienei & Steve Wanjala & Francis Varaine & Maryline Bonnet & Helena Huerga, 2020. "Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis," PLOS ONE, Public Library of Science, vol. 15(1), pages 1-17, January.
  361. Herrera, Marcos, 2015. "Heterogeneidad geográfica en la calidad de vida relacionada con la salud. Análisis multinivel para Argentina/Geographical Heterogeneity in the Quality of Life Related to Health. Multilevel Analysis fo," Estudios de Economia Aplicada, Estudios de Economia Aplicada, vol. 33, pages 119-144, Enero.
  362. Falk Schwendicke & Hendrik Meyer-Lueckel & Michael Stolpe & Christof Edmund Dörfer & Sebastian Paris, 2014. "Costs and Effectiveness of Treatment Alternatives for Proximal Caries Lesions," PLOS ONE, Public Library of Science, vol. 9(1), pages 1-10, January.
  363. Malin Ulfsdotter & Lene Lindberg & Anna Månsdotter, 2015. "A Cost-Effectiveness Analysis of the Swedish Universal Parenting Program All Children in Focus," PLOS ONE, Public Library of Science, vol. 10(12), pages 1-16, December.
  364. Sanjib Saha & Katarina Steen Carlsson & Ulf-G Gerdtham & Margareta K Eriksson & Lars Hagberg & Mats Eliasson & Pia Johansson, 2013. "Are Lifestyle Interventions in Primary Care Cost-Effective? – An Analysis Based on a Markov Model, Differences-In-Differences Approach and the Swedish Björknäs Study," PLOS ONE, Public Library of Science, vol. 8(11), pages 1-1, November.
  365. Judit Simon & Stavros Petrou & Alastair Gray, 2009. "The valuation of prenatal life in economic evaluations of perinatal interventions," Health Economics, John Wiley & Sons, Ltd., vol. 18(4), pages 487-494, April.
  366. France R. M. Portrait & Onno van der Galiën & Bernard Van den Berg, 2016. "Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators," Health Economics, John Wiley & Sons, Ltd., vol. 25(4), pages 408-423, April.
  367. Syed Mohiuddin, 2014. "A Systematic and Critical Review of Model-Based Economic Evaluations of Pharmacotherapeutics in Patients with Bipolar Disorder," Applied Health Economics and Health Policy, Springer, vol. 12(4), pages 359-372, August.
  368. van den Berg, Bernard & Gafni, Amiram & Portrait, France, 2017. "Attributing a monetary value to patients' time: A contingent valuation approach," Social Science & Medicine, Elsevier, vol. 179(C), pages 182-190.
  369. Brousselle, Astrid & Lessard, Chantale, 2011. "Economic evaluation to inform health care decision-making: Promise, pitfalls and a proposal for an alternative path," Social Science & Medicine, Elsevier, vol. 72(6), pages 832-839, March.
  370. Lisa R. Ulrich & Juliana J. Petersen & Karola Mergenthal & Andrea Berghold & Gudrun Pregartner & Rolf Holle & Andrea Siebenhofer, 2019. "Cost-effectiveness analysis of case management for optimized antithrombotic treatment in German general practices compared to usual care – results from the PICANT trial," Health Economics Review, Springer, vol. 9(1), pages 1-10, December.
  371. Cindy Canivet & Nadège Costa & Fabienne Ory-Magne & Céline Arcari & Christine Mohara & Laure Pourcel & Hélène Derumeaux & Emilie Bérard & Robert Bourrel & Laurent Molinier & Christine Brefel-Courbon, 2016. "Clinical Impact and Cost-Effectiveness of an Education Program for PD Patients: A Randomized Controlled Trial," PLOS ONE, Public Library of Science, vol. 11(9), pages 1-14, September.
  372. Neily Zakiyah & Antoinette D I van Asselt & Frank Roijmans & Maarten J Postma, 2016. "Economic Evaluation of Family Planning Interventions in Low and Middle Income Countries; A Systematic Review," PLOS ONE, Public Library of Science, vol. 11(12), pages 1-19, December.
  373. Tom Drake, 2014. "Priority Setting In Global Health: Towards A Minimum Daly Value," Health Economics, John Wiley & Sons, Ltd., vol. 23(2), pages 248-252, February.
  374. Ioana Popovici & Michael T. French & James R. McKay, 2008. "Economic Evaluation of Continuing Care Interventions in the Treatment of Substance Abuse," Evaluation Review, , vol. 32(6), pages 547-568, December.
  375. Neyt, Mattias & Cleemput, Irina & Thiry, Nancy & De Laet, Chris, 2012. "Calculating an intervention's (cost-)effectiveness for the real-world target population: The potential of combining strengths of both RCTs and observational data," Health Policy, Elsevier, vol. 106(2), pages 207-210.
  376. Bruce Hollingsworth, 2012. "Revolution, evolution, or status quo? Guidelines for efficiency measurement in health care," Journal of Productivity Analysis, Springer, vol. 37(1), pages 1-5, February.
  377. Moger, Tron Anders & Kristiansen, Ivar Sønbø, 2012. "Direct and indirect costs of the Norwegian Breast Cancer Screening Program," HERO Online Working Paper Series 2012:3, University of Oslo, Health Economics Research Programme.
  378. Marcelo Soto & Laura Sampietro-Colom & Anna Vilella & Efrain Pantoja & Maria Asenjo & Ruth Arjona & Juan Carlos Hurtado & Antoni Trilla & Miriam Jose Alvarez-Martinez & Aurea Mira & Jordi Vila & Maria, 2016. "Economic Impact of a New Rapid PCR Assay for Detecting Influenza Virus in an Emergency Department and Hospitalized Patients," PLOS ONE, Public Library of Science, vol. 11(1), pages 1-10, January.
  379. Jaana T Joensuu & Saara Huoponen & Kalle J Aaltonen & Yrjö T Konttinen & Dan Nordström & Marja Blom, 2015. "The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review," PLOS ONE, Public Library of Science, vol. 10(3), pages 1-27, March.
  380. Torbjørn Wisløff & Gunhild Hagen & Vida Hamidi & Espen Movik & Marianne Klemp & Jan Olsen, 2014. "Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010," PharmacoEconomics, Springer, vol. 32(4), pages 367-375, April.
  381. Henry Zheng & Fred Ehrlich & Janaki Amin, 2010. "Productivity loss resulting from coronary heart disease in Australia," Applied Health Economics and Health Policy, Springer, vol. 8(3), pages 179-189, May.
  382. Silke Wolfenstetter & Christina Wenig, 2011. "Costing of physical activity programmes in primary prevention: a review of the literature," Health Economics Review, Springer, vol. 1(1), pages 1-15, December.
  383. Julien Forder & Juliette Malley & Ann‐Marie Towers & Ann Netten, 2014. "Using Cost‐Effectiveness Estimates From Survey Data To Guide Commissioning: An Application To Home Care," Health Economics, John Wiley & Sons, Ltd., vol. 23(8), pages 979-992, August.
  384. S. Tan & F. Rutten & B. Ineveld & W. Redekop & L. Hakkaart-van Roijen, 2009. "Comparing methodologies for the cost estimation of hospital services," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(1), pages 39-45, February.
  385. Boone, Jan, 2018. "Basic versus supplementary health insurance: Access to care and the role of cost effectiveness," Journal of Health Economics, Elsevier, vol. 60(C), pages 53-74.
  386. Hirsch Ruchlin & Ralph Insinga, 2008. "A Review of Health-Utility Data for Osteoarthritis," PharmacoEconomics, Springer, vol. 26(11), pages 925-935, November.
  387. Brazier, J & Rowen, D & Yang, Y & Tsuchiya, A, 2009. "Using rank and discrete choice data to estimate health state utility values on the QALY scale," MPRA Paper 29891, University Library of Munich, Germany.
  388. Andronis, Lazaros & Maredza, Mandy & Petrou, Stavros, 2019. "Measuring, valuing and including forgone childhood education and leisure time costs in economic evaluation: Methods, challenges and the way forward," Social Science & Medicine, Elsevier, vol. 237(C), pages 1-1.
  389. Frank Pega & Nick Wilson, 2016. "A Systematic Review of Health Economic Analyses of Housing Improvement Interventions and Insecticide-Treated Bednets in the Home," PLOS ONE, Public Library of Science, vol. 11(6), pages 1-29, June.
  390. Michela Tinelli & Mandy Ryan & Christine Bond & Anthony Scott, 2013. "Valuing Benefits to Inform a Clinical Trial in Pharmacy," PharmacoEconomics, Springer, vol. 31(2), pages 163-171, February.
  391. Panos Kanavos & Olivier Wouters & Mackenzie Mills & Nicola Boekstein & Maxine Mackintosh & Panos Kanavos, 2017. "Towards High Quality Health Care and Sustainable Financing – the Role of Health Care Programmes," Global Policy, London School of Economics and Political Science, vol. 8(s2), pages 46-59, March.
  392. Manuel Gomes & Richard Grieve & Richard Nixon & W. J. Edmunds, 2012. "Statistical Methods for Cost-Effectiveness Analyses That Use Data from Cluster Randomized Trials," Medical Decision Making, , vol. 32(1), pages 209-220, January.
  393. Billingsley Kaambwa & Julie Ratcliffe, 2018. "Predicting EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) Utilities from Older People’s Quality of Life Brief Questionnaire (OPQoL-Brief) Scores," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 11(1), pages 39-54, February.
  394. Lazaros Andronis & Philip Kinghorn & Suyin Qiao & David G. T. Whitehurst & Susie Durrell & Hugh McLeod, 2017. "Cost-Effectiveness of Non-Invasive and Non-Pharmacological Interventions for Low Back Pain: a Systematic Literature Review," Applied Health Economics and Health Policy, Springer, vol. 15(2), pages 173-201, April.
  395. Lisanne I. Lier & Judith E. Bosmans & Hein P. J. Hout & Lidwine B. Mokkink & Wilbert B. Hout & G. Ardine Wit & Carmen D. Dirksen & Henk L. G. R. Nies & Cees M. P. M. Hertogh & Henriëtte G. Roest, 2018. "Consensus-based cross-European recommendations for the identification, measurement and valuation of costs in health economic evaluations: a European Delphi study," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(7), pages 993-1008, September.
  396. Olivia Oxlade & Marcia Pinto & Anete Trajman & Dick Menzies, 2013. "How Methodologic Differences Affect Results of Economic Analyses: A Systematic Review of Interferon Gamma Release Assays for the Diagnosis of LTBI," PLOS ONE, Public Library of Science, vol. 8(3), pages 1-11, March.
  397. Wildman, John & McMeekin, Peter & Grieve, Eleanor & Briggs, Andrew, 2016. "Economic evaluation of integrated new technologies for health and social care: Suggestions for policy makers, users and evaluators," Social Science & Medicine, Elsevier, vol. 169(C), pages 141-148.
  398. Zafar Zafari & Kristian Thorlund & J. FitzGerald & Carlo Marra & Mohsen Sadatsafavi, 2014. "Network vs. Pairwise Meta-Analyses: A Case Study of the Impact of an Evidence-Synthesis Paradigm on Value of Information Outcomes," PharmacoEconomics, Springer, vol. 32(10), pages 995-1004, October.
  399. Paul Jülicher & Vladimir P Chulanov & Nikolay N Pimenov & Ekaterina Chirkova & Anna Yankina & Claudio Galli, 2019. "Streamlining the screening cascade for active Hepatitis C in Russia: A cost-effectiveness analysis," PLOS ONE, Public Library of Science, vol. 14(7), pages 1-22, July.
  400. Jeroen T J M van Dijck & Mark D Dijkman & Robbin H Ophuis & Godard C W de Ruiter & Wilco C Peul & Suzanne Polinder, 2019. "In-hospital costs after severe traumatic brain injury: A systematic review and quality assessment," PLOS ONE, Public Library of Science, vol. 14(5), pages 1-21, May.
  401. Kathryn Schnippel & Naomi Lince-Deroche & Theo van den Handel & Seithati Molefi & Suann Bruce & Cynthia Firnhaber, 2015. "Cost Evaluation of Reproductive and Primary Health Care Mobile Service Delivery for Women in Two Rural Districts in South Africa," PLOS ONE, Public Library of Science, vol. 10(3), pages 1-13, March.
  402. Vanessa Scarf & Christine Catling & Rosalie Viney & Caroline Homer, 2016. "Costing Alternative Birth Settings for Women at Low Risk of Complications: A Systematic Review," PLOS ONE, Public Library of Science, vol. 11(2), pages 1-17, February.
  403. Karimi, M. & Brazier, J. & Paisley, S., 2017. "How do individuals value health states? A qualitative investigation," Social Science & Medicine, Elsevier, vol. 172(C), pages 80-88.
  404. L. M. Lamers & J. McDonnell & P. F. M. Stalmeier & P. F. M. Krabbe & J. J. V. Busschbach, 2006. "The Dutch tariff: results and arguments for an effective design for national EQ‐5D valuation studies," Health Economics, John Wiley & Sons, Ltd., vol. 15(10), pages 1121-1132, October.
  405. Iain Willits & Kim Keltie & Joyce Craig & Andrew Sims, 2014. "WatchBP Home A for Opportunistically Detecting Atrial Fibrillation During Diagnosis and Monitoring of Hypertension: A NICE Medical Technology Guidance," Applied Health Economics and Health Policy, Springer, vol. 12(3), pages 255-265, June.
  406. Anthony Newall & Juan Dehollain & Prudence Creighton & Philippe Beutels & James Wood, 2013. "Understanding the Cost-Effectiveness of Influenza Vaccination in Children: Methodological Choices and Seasonal Variability," PharmacoEconomics, Springer, vol. 31(8), pages 693-702, August.
  407. Ilias Goranitis & Leana Bellanca & Amanda J Daley & Adele Thomas & Helen Stokes-Lampard & Andrea K Roalfe & Sue Jowett, 2017. "Aerobic exercise for vasomotor menopausal symptoms: A cost-utility analysis based on the Active Women trial," PLOS ONE, Public Library of Science, vol. 12(9), pages 1-15, September.
  408. Emelie Heintz & Andreas Gerber-Grote & Salah Ghabri & Francoise Hamers & Valentina Rupel & Renata Slabe-Erker & Thomas Davidson, 2016. "Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries," PharmacoEconomics, Springer, vol. 34(1), pages 59-76, January.
  409. Carl Tilling & Nancy Devlin & Aki Tsuchiya & Ken Buckingham, 2010. "Protocols for Time Tradeoff Valuations of Health States Worse than Dead: A Literature Review," Medical Decision Making, , vol. 30(5), pages 610-619, September.
  410. C. Elizabeth McCarron & Eleanor M. Pullenayegum & Lehana Thabane & Ron Goeree & Jean-Eric Tarride, 2013. "The Impact of Using Informative Priors in a Bayesian Cost-Effectiveness Analysis," Medical Decision Making, , vol. 33(3), pages 437-450, April.
  411. Edward Wilson, 2015. "A Practical Guide to Value of Information Analysis," PharmacoEconomics, Springer, vol. 33(2), pages 105-121, February.
  412. Subramanian, Sujha & Tangka, Florence K.L. & Hoover, Sonja & Royalty, Janet & DeGroff, Amy & Joseph, Djenaba, 2017. "Costs of colorectal cancer screening provision in CDC’s Colorectal Cancer Control Program: Comparisons of colonoscopy and FOBT/FIT based screening," Evaluation and Program Planning, Elsevier, vol. 62(C), pages 73-80.
  413. Diana Albrecht & Tanja Wollensak & Christian Ernst & Clemens Becker & Martin Hautzinger & Klaus Pfeiffer, 2016. "Costs of informal care in a sample of German geriatric stroke survivors," European Journal of Ageing, Springer, vol. 13(1), pages 49-61, March.
  414. Susanne Löfgren & Clas Rehnberg & Gunnar Ljunggren & Mats Brommels, 2015. "Coordination pays off: a comparison of two models for organizing hip fracture care, outcomes and costs," International Journal of Health Planning and Management, Wiley Blackwell, vol. 30(4), pages 426-438, October.
  415. Andrea Iannaccone & Thomas Marwick, 2015. "Cost Effectiveness of Transcatheter Aortic Valve Replacement Compared with Medical Management or Surgery for Patients with Aortic Stenosis," Applied Health Economics and Health Policy, Springer, vol. 13(1), pages 29-45, February.
  416. Rachel Elliott & Koen Putman & James Davies & Lieven Annemans, 2014. "A Review of the Methodological Challenges in Assessing the Cost Effectiveness of Pharmacist Interventions," PharmacoEconomics, Springer, vol. 32(12), pages 1185-1199, December.
  417. Boone, Jan, 2018. "Competition in health care markets: treatment volume and quality," CEPR Discussion Papers 12853, C.E.P.R. Discussion Papers.
  418. Naomi Lince-Deroche & Jane Phiri & Pam Michelow & Jennifer S Smith & Cindy Firnhaber, 2015. "Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa," PLOS ONE, Public Library of Science, vol. 10(11), pages 1-16, November.
  419. Devlin, N. & Tsuchiya, A. & Buckingham, K. & Tilling, C., 2009. "A uniform Time Trade Off method for states better and worse than dead: feasibility study of the ‘lead time’ approach," Working Papers 09/08, Department of Economics, City University London.
  420. Kirsten Howard & Glenn Salkeld & Kirsten McCaffery & Les Irwig, 2008. "HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility?," Health Economics, John Wiley & Sons, Ltd., vol. 17(5), pages 593-605, May.
  421. Anne-Marie Turcotte-Tremblay & Jessica Spagnolo & Manuela De Allegri & Valéry Ridde, 2016. "Does performance-based financing increase value for money in low- and middle- income countries? A systematic review," Health Economics Review, Springer, vol. 6(1), pages 1-18, December.
  422. Holly Essex & Steve Parrott & Karl Atkin & Kathleen Ballard & Martin Bland & Janet Eldred & Catherine Hewitt & Ann Hopton & Ada Keding & Harriet Lansdown & Stewart Richmond & Helen Tilbrook & David To, 2017. "An economic evaluation of Alexander Technique lessons or acupuncture sessions for patients with chronic neck pain: A randomized trial (ATLAS)," PLOS ONE, Public Library of Science, vol. 12(12), pages 1-16, December.
  423. Neily Zakiyah & Maarten Postma & Philip Baker & Antoinette Asselt, 2015. "Pre-eclampsia Diagnosis and Treatment Options: A Review of Published Economic Assessments," PharmacoEconomics, Springer, vol. 33(10), pages 1069-1082, October.
  424. Bethany Cooper & Walter O. Okello, 2021. "An economic lens to understanding antimicrobial resistance: disruptive cases to livestock and wastewater management in Australia," Australian Journal of Agricultural and Resource Economics, Australian Agricultural and Resource Economics Society, vol. 65(4), pages 900-917, October.
  425. Lorgelly, Paula K. & Lorimer, Karen & Fenwick, Elisabeth A.L. & Briggs, Andrew H. & Anand, Paul, 2015. "Operationalising the capability approach as an outcome measure in public health: The development of the OCAP-18," Social Science & Medicine, Elsevier, vol. 142(C), pages 68-81.
  426. Phantipa Sakthong & Wipaporn Munpan, 2017. "A Head-to-Head Comparison of UK SF-6D and Thai and UK EQ-5D-5L Value Sets in Thai Patients with Chronic Diseases," Applied Health Economics and Health Policy, Springer, vol. 15(5), pages 669-679, October.
  427. Anna Månsdotter & Björn Ekman & Inna Feldman & Lars Hagberg & Anna-Karin Hurtig & Lars Lindholm, 2017. "We Propose a Novel Measure for Social Welfare and Public Health: Capability-Adjusted Life-Years, CALYs," Applied Health Economics and Health Policy, Springer, vol. 15(4), pages 437-440, August.
  428. Watson, Verity & Ryan, Mandy, 2007. "Exploring preference anomalies in double bounded contingent valuation," Journal of Health Economics, Elsevier, vol. 26(3), pages 463-482, May.
  429. Abaigeal D. Jackson & Andrew L. Jackson & Godfrey Fletcher & Gerardine Doyle & Mary Harrington & Shijun Zhou & Fiona Cullinane & Charles Gallagher & Edward McKone, 2017. "Estimating Direct Cost of Cystic Fibrosis Care Using Irish Registry Healthcare Resource Utilisation Data, 2008–2012," PharmacoEconomics, Springer, vol. 35(10), pages 1087-1101, October.
  430. K. Klose & S. Kreimeier & U. Tangermann & I. Aumann & K. Damm, 2016. "Patient- and person-reports on healthcare: preferences, outcomes, experiences, and satisfaction – an essay," Health Economics Review, Springer, vol. 6(1), pages 1-11, December.
  431. Elias Asfaw Zegeye & Josue Mbonigaba & Sylvia Blanche Kaye & Thomas Wilkinson, 2017. "Economic Evaluation in Ethiopian Healthcare Sector Decision Making: Perception, Practice and Barriers," Applied Health Economics and Health Policy, Springer, vol. 15(1), pages 33-43, February.
  432. Neil J. Buckley & Katherine Cuff & Jeremiah Hurley & Logan McLeod & Robert Nuscheler & David Cameron, 2012. "Willingness-to-pay for parallel private health insurance: evidence from a laboratory experiment," Canadian Journal of Economics, Canadian Economics Association, vol. 45(1), pages 137-166, February.
  433. Nikolina Dukic Samarzija & Andrea Arbula Blecich & Luka Samarzija, 2018. "The Paradigm Of Patient-Centered Care In The Public Health Decision-Making," Economic Thought and Practice, Department of Economics and Business, University of Dubrovnik, vol. 27(2), pages 503-516, december.
  434. José L Burgos & Julia A Gaebler & Steffanie A Strathdee & Remedios Lozada & Hugo Staines & Thomas L Patterson, 2010. "Cost-Effectiveness of an Intervention to Reduce HIV/STI Incidence and Promote Condom Use among Female Sex Workers in the Mexico–US Border Region," PLOS ONE, Public Library of Science, vol. 5(6), pages 1-10, June.
  435. Themba G Ginindza & Benn Sartorius & Xolisile Dlamini & Ellinor Östensson, 2017. "Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland," PLOS ONE, Public Library of Science, vol. 12(5), pages 1-16, May.
  436. Samer A. Kharroubi & Donna Rowen, 2019. "Valuation of preference-based measures: can existing preference data be used to select a smaller sample of health states?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(2), pages 245-255, March.
  437. Paul Dolan & Aki Tsuchiya, 2011. "Determining the parameters in a social welfare function using stated preference data: an application to health," Applied Economics, Taylor & Francis Journals, vol. 43(18), pages 2241-2250.
  438. Le, Ha N.D. & Gold, Lisa & Abbott, Gavin & Crawford, David & McNaughton, Sarah A. & Mhurchu, Cliona Ni & Pollard, Christina & Ball, Kylie, 2016. "Economic evaluation of price discounts and skill-building strategies on purchase and consumption of healthy food and beverages: The SHELf randomized controlled trial," Social Science & Medicine, Elsevier, vol. 159(C), pages 83-91.
  439. Park, A-La & McDaid, David & Weiser, Prisca & von Gottberg, Carolin & Becker, Thomas & Kilian, Reinhold, 2013. "Examining the cost effectiveness of interventions to promote the physical health of people with mental health problems: a systematic review," LSE Research Online Documents on Economics 52157, London School of Economics and Political Science, LSE Library.
  440. Maduka Donatus Ughasoro & James Onuorah Akpeh & Nneamaka Echendu & Somkene Okpala & Nneka Getrude Mgbachi & Ogochukwu Chinelo Okanya & Obinna Emmanuel Onwujekwe, 2021. "Direct and Indirect Costs of Non-surgical Treatment for Acute Tonsillitis in Children in Southeast Nigeria," PharmacoEconomics - Open, Springer, vol. 5(4), pages 755-764, December.
  441. Samanta Pereira Sussenbach & Everton Nunes Silva & Milene Amarante Pufal & Daniela Shan Casagrande & Alexandre Vontobel Padoin & Cláudio Corá Mottin, 2014. "Systematic Review of Economic Evaluation of Laparotomy versus Laparoscopy for Patients Submitted to Roux-en-Y Gastric Bypass," PLOS ONE, Public Library of Science, vol. 9(6), pages 1-8, June.
  442. Mayvis Rebeira & Eric Nauenberg, 2021. "Consideration of Trade-offs Regarding COVID-19 Containment Measures in the United States: Implications for Canada," Working Papers 210003, Canadian Centre for Health Economics.
  443. Jackson, Louise J. & Roberts, Tracy E., 2015. "Conceptualising quality of life outcomes for women participating in testing for sexually transmitted infections: A systematic review and meta-synthesis of qualitative research," Social Science & Medicine, Elsevier, vol. 143(C), pages 162-170.
  444. Grégoire Mercier & Gérald Naro, 2014. "Costing Hospital Surgery Services: The Method Matters," Post-Print hal-01829947, HAL.
  445. Mark Oremus & Jean-Eric Tarride & Eleanor Pullenayegum & Natasha Clayton & Parminder Raina, 2013. "Patients’ Willingness-to-Pay for an Alzheimer’s Disease Medication in Canada," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 6(3), pages 161-168, September.
  446. Stavros Petrou & Emil Kupek, 2009. "Estimating Preference-Based Health Utilities Index Mark 3 Utility Scores for Childhood Conditions in England and Scotland," Medical Decision Making, , vol. 29(3), pages 291-303, May.
  447. Øystein Ariansen Haaland & Frode Lindemark & Kjell Arne Johansson, 2019. "A flexible formula for incorporating distributive concerns into cost-effectiveness analyses: Priority weights," PLOS ONE, Public Library of Science, vol. 14(10), pages 1-12, October.
  448. Maria Gheorghe & Werner Brouwer & Pieter Baal, 2015. "Did the health of the Dutch population improve between 2001 and 2008? Investigating age- and gender-specific trends in quality of life," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(8), pages 801-811, November.
  449. Craig, Benjamin M. & Oppe, Mark, 2010. "From a different angle: A novel approach to health valuation," Social Science & Medicine, Elsevier, vol. 70(2), pages 169-174, January.
  450. Ya-Chen Shih & Nebiyou Bekele & Ying Xu, 2007. "Use of Bayesian Net Benefit Regression Model to Examine the Impact of Generic Drug Entry on the Cost Effectiveness of Selective Serotonin Reuptake Inhibitors in Elderly Depressed Patients," PharmacoEconomics, Springer, vol. 25(10), pages 843-862, October.
  451. Elizabeth Goodwin & Colin Green, 2016. "A Systematic Review of the Literature on the Development of Condition-Specific Preference-Based Measures of Health," Applied Health Economics and Health Policy, Springer, vol. 14(2), pages 161-183, April.
  452. Sara Atehortúa, 2013. "Evaluación de la calidad metodológica de la literatura en evaluación económica en salud en Colombia: una revisión sistemática," Publicaciones 15616, Grupo de Economía de la Salud.
  453. Natasja H J van Veen & Paul McNamee & Jan Hendrik Richardus & W Cairns S Smith, 2009. "Cost-Effectiveness of Interventions to Prevent Disability in Leprosy: A Systematic Review," PLOS ONE, Public Library of Science, vol. 4(2), pages 1-7, February.
  454. Pieter Baal & Alec Morton & David Meltzer & Werner Brouwer, 2019. "Future unrelated medical costs need to be considered in cost effectiveness analysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(1), pages 1-5, February.
  455. Maria Gheorghe & Werner B. F. Brouwer & Pieter H. M. van Baal, 2015. "Quality of Life and Time to Death," Medical Decision Making, , vol. 35(3), pages 316-327, April.
  456. Subramanian, Sujha & Tangka, Florence K.L. & Beebe, Maggie Cole & Trebino, Diana & Weir, Hannah K. & Babcock, Frances, 2016. "The cost of cancer registry operations: Impact of volume on cost per case for core and enhanced registry activities," Evaluation and Program Planning, Elsevier, vol. 55(C), pages 1-8.
  457. Eliana Jimenez-Soto & Andrew Hodge & Kim-Huong Nguyen & Zoe Dettrick & Alan D Lopez, 2014. "A Framework for the Economic Analysis of Data Collection Methods for Vital Statistics," PLOS ONE, Public Library of Science, vol. 9(8), pages 1-12, August.
  458. Phillips, V.L. & Teweldemedhin, B. & Ahmedov, S. & Cobb, J. & McNabb, S.J.N., 2010. "Evaluation of program performance and expenditures in a report of performance measures (RPM) via a case study of two Florida county tuberculosis programs," Evaluation and Program Planning, Elsevier, vol. 33(4), pages 373-378, November.
  459. Grupp, Helen & König, Hans-Helmut & Konnopka, Alexander, 2016. "Health care utilisation and costs in the general population in Germany," Health Policy, Elsevier, vol. 120(2), pages 159-169.
  460. Jeffrey Hoch & Carolyn Dewa, 2007. "Lessons from Trial-Based Cost-Effectiveness Analyses of Mental Health Interventions," PharmacoEconomics, Springer, vol. 25(10), pages 807-816, October.
  461. Markian Pahuta & Aaron Frombach & Emile Hashem & Stewart Spence & Christina Sun & Eugene K. Wai & Joel Werier & Carl Walraven & Doug Coyle, 2019. "The Psychometric Properties of a Self-Administered, Open-Source Module for Valuing Metastatic Epidural Spinal Cord Compression Utilities," PharmacoEconomics - Open, Springer, vol. 3(2), pages 197-204, June.
  462. Els Meeuwsen & René Melis & Geert van der Aa & Gertie Golüke-Willemse & Benoit de Leest & Frank van Raak & Carla Schölzel-Dorenbos & Desiree Verheijen & Frans Verhey & Marieke Visser & Claire Wolfs & , 2013. "Cost-Effectiveness of One Year Dementia Follow-Up Care by Memory Clinics or General Practitioners: Economic Evaluation of a Randomised Controlled Trial," PLOS ONE, Public Library of Science, vol. 8(11), pages 1-7, November.
  463. Christian Kronborg & Gitte Handberg & Flemming Axelsen, 2009. "Health care costs, work productivity and activity impairment in non-malignant chronic pain patients," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(1), pages 5-13, February.
  464. Marlies T van Dalen & Jacqueline J Suijker & Janet MacNeil-Vroomen & Marjon van Rijn & Eric P Moll van Charante & Sophia E de Rooij & Bianca M Buurman, 2014. "Self-Report of Healthcare Utilization among Community-Dwelling Older Persons: A Prospective Cohort Study," PLOS ONE, Public Library of Science, vol. 9(4), pages 1-11, April.
  465. Edward Wilson & David Price & Stanley Musgrave & Erika Sims & Lee Shepstone & Jamie Murdoch & H. Mugford & Annie Blyth & Elizabeth Juniper & Jon Ayres & Stephanie Wolfe & Daryl Freeman & Richard Gilbe, 2010. "Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma," PharmacoEconomics, Springer, vol. 28(7), pages 597-608, July.
  466. Yoel Lubell & Sarah G Staedke & Brian M Greenwood & Moses R Kamya & Malcolm Molyneux & Paul N Newton & Hugh Reyburn & Robert W Snow & Umberto D'Alessandro & Mike English & Nick Day & Peter Kremsner & , 2011. "Likely Health Outcomes for Untreated Acute Febrile Illness in the Tropics in Decision and Economic Models; A Delphi Survey," PLOS ONE, Public Library of Science, vol. 6(2), pages 1-9, February.
  467. Aulo Gelli & Francisco Espejo & Jing Shen & Elizabeth Kristjansson, 2014. "Putting It All Together: Aggregating Impacts of School-Feeding Programmes on Education, Health and Nutrition: Two Proposed Methodologies," WIDER Working Paper Series wp-2014-036, World Institute for Development Economic Research (UNU-WIDER).
  468. Andrew Keller & Christian Gericke & Jennifer A. Whitty & John Yaxley & Boon Kua & Geoff Coughlin & Troy Gianduzzo, 2017. "A Cost-Utility Analysis of Prostate Cancer Screening in Australia," Applied Health Economics and Health Policy, Springer, vol. 15(1), pages 95-111, February.
  469. Leiter, Andrea & Thöni, Magdalena & Winner, Hannes, 2012. "Evaluating human life using court decisions on damages for pain and suffering," International Review of Law and Economics, Elsevier, vol. 32(1), pages 119-128.
  470. Alessandro G. Campolina & Luciana M. Rozman & Tassia C. Decimoni & Roseli Leandro & Hillegonda M. D. Novaes & Patrícia Coelho De Soárez, 2017. "Many Miles to Go: A Systematic Review of the State of Cost-Utility Analyses in Brazil," Applied Health Economics and Health Policy, Springer, vol. 15(2), pages 163-172, April.
  471. Billingsley Kaambwa & Gang Chen & Julie Ratcliffe & Angelo Iezzi & Aimee Maxwell & Jeff Richardson, 2017. "Mapping Between the Sydney Asthma Quality of Life Questionnaire (AQLQ-S) and Five Multi-Attribute Utility Instruments (MAUIs)," PharmacoEconomics, Springer, vol. 35(1), pages 111-124, January.
  472. Tobias Sydendal Grand & Hasan Basarir & Louise J Jackson, 2019. "The cost-effectiveness of oral contraceptives compared to ‘no hormonal treatment’ for endometriosis-related pain: An economic evaluation," PLOS ONE, Public Library of Science, vol. 14(1), pages 1-16, January.
  473. Amani Thomas Mori & Peter Binyaruka & Peter Hangoma & Bjarne Robberstad & Ingvild Sandoy, 2020. "Patient and health system costs of managing pregnancy and birth-related complications in sub-Saharan Africa: a systematic review," Health Economics Review, Springer, vol. 10(1), pages 1-15, December.
  474. Kenneth Tang, 2015. "Estimating Productivity Costs in Health Economic Evaluations: A Review of Instruments and Psychometric Evidence," PharmacoEconomics, Springer, vol. 33(1), pages 31-48, January.
  475. Al-Janabi, Hareth & Wittenberg, Eve & Donaldson, Cam & Brouwer, Werner, 2022. "The relative value of carer and patient quality of life: A person trade-off (PTO) study," Social Science & Medicine, Elsevier, vol. 292(C).
  476. Catherine Milte & Ruth Walker & Mary Luszcz & Emily Lancsar & Billingsley Kaambwa & Julie Ratcliffe, 2014. "How Important Is Health Status in Defining Quality of Life for Older People? An Exploratory Study of the Views of Older South Australians," Applied Health Economics and Health Policy, Springer, vol. 12(1), pages 73-84, February.
  477. Nicholas Graves & Mary Courtney & Helen Edwards & Anne Chang & Anthony Parker & Kathleen Finlayson, 2009. "Cost-Effectiveness of an Intervention to Reduce Emergency Re-Admissions to Hospital among Older Patients," PLOS ONE, Public Library of Science, vol. 4(10), pages 1-9, October.
  478. Pedersen, Line Bjørnskov & Gyrd-Hansen, Dorte & Kjær, Trine, 2011. "The influence of information and private versus public provision on preferences for screening for prostate cancer: A willingness-to-pay study," Health Policy, Elsevier, vol. 101(3), pages 277-289, August.
  479. Samer A. Kharroubi, 2021. "Modeling SF-6D Health Utilities: Is Bayesian Approach Appropriate?," IJERPH, MDPI, vol. 18(16), pages 1-14, August.
  480. Ifigeneia Mavranezouli, 2010. "A Review and Critique of Studies Reporting Utility Values for Schizophrenia-Related Health States," PharmacoEconomics, Springer, vol. 28(12), pages 1109-1121, December.
  481. P. Wang & M. Li & G. Liu & J. Thumboo & N. Luo, 2015. "Do Chinese have similar health-state preferences? A comparison of mainland Chinese and Singaporean Chinese," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(8), pages 857-863, November.
  482. Lairson, David R. & Huo, Jinhai & Ball Ricks, Katharine A. & Savas, Lara & Fernández, María E., 2013. "The cost of implementing a 2-1-1 call center-based cancer control navigator program," Evaluation and Program Planning, Elsevier, vol. 39(C), pages 51-56.
  483. Brandon S Walker & Richard E Nelson & Brian R Jackson & David G Grenache & Edward R Ashwood & Robert L Schmidt, 2015. "A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States," PLOS ONE, Public Library of Science, vol. 10(7), pages 1-20, July.
  484. Airoldi, Mara & Morton, Alec & Bevan, Gwyn & Smith, Jennifer, 2014. "STAR — people-powered prioritization: a 21st-century solution to allocation headaches," LSE Research Online Documents on Economics 51299, London School of Economics and Political Science, LSE Library.
  485. Francis Fatoye & Carol Haigh, 2016. "The cost‐effectiveness of semi‐rigid ankle brace to facilitate return to work following first‐time acute ankle sprains," Journal of Clinical Nursing, John Wiley & Sons, vol. 25(9-10), pages 1435-1443, May.
  486. Samuel N. Frempong & Andrew J. Sutton & Clare Davenport & Pelham Barton, 2020. "Early Economic Evaluation to Identify the Necessary Test Characteristics of a New Typhoid Test to be Cost Effective in Ghana," PharmacoEconomics - Open, Springer, vol. 4(1), pages 143-157, March.
  487. Stuart Turner & Jack Brown & Joseph Paladino, 2013. "Protease Inhibitors for Hepatitis C: Economic Implications," PharmacoEconomics, Springer, vol. 31(9), pages 739-751, September.
  488. Liv Ariane Augestad & Kim Rand-Hendriksen & Ivar Sønbø Kristiansen & Knut Stavem, 2012. "Impact of Transformation of Negative Values and Regression Models on Differences Between the UK and US EQ-5D Time Trade-Off Value Sets," PharmacoEconomics, Springer, vol. 30(12), pages 1203-1214, December.
  489. Patricia Akweongo & Maxwell A Dalaba & Mary H Hayden & Timothy Awine & Gertrude N Nyaaba & Dominic Anaseba & Abraham Hodgson & Abdulai A Forgor & Rajul Pandya, 2013. "The Economic Burden of Meningitis to Households in Kassena-Nankana District of Northern Ghana," PLOS ONE, Public Library of Science, vol. 8(11), pages 1-6, November.
  490. Pelham Barton, 2011. "What happens to value of information measures as the number of decision options increases?," Health Economics, John Wiley & Sons, Ltd., vol. 20(7), pages 853-863, July.
  491. Mercy G. Mugo & Peterson J. Muriithi, 2018. "Cost Effectiveness Analysis of Family Planning Provision in Kenya," Journal of African Development, African Finance and Economic Association (AFEA), vol. 20(1), pages 13-22.
  492. Lakdawalla, Darius & Malani, Anup & Reif, Julian, 2017. "The insurance value of medical innovation," Journal of Public Economics, Elsevier, vol. 145(C), pages 94-102.
  493. Kris Doggen & Albert Jan van Hoek & Jeroen Luyten, 2023. "Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meni," PharmacoEconomics, Springer, vol. 41(5), pages 481-497, May.
  494. David Feeny, 2012. "The Multi-attribute Utility Approach to Assessing Health-related Quality of Life," Chapters, in: Andrew M. Jones (ed.), The Elgar Companion to Health Economics, Second Edition, chapter 36, Edward Elgar Publishing.
  495. Mara Airoldi & Alec Morton, 2009. "Adjusting life for quality or disability: stylistic difference or substantial dispute?," Health Economics, John Wiley & Sons, Ltd., vol. 18(11), pages 1237-1247, November.
  496. Marieke Krol & Werner Brouwer, 2014. "How to Estimate Productivity Costs in Economic Evaluations," PharmacoEconomics, Springer, vol. 32(4), pages 335-344, April.
  497. te Velde, Saskia J. & Lennert Veerman, J. & Tak, Nannah I. & Bosmans, Judith E. & Klepp, Knut-Inge & Brug, Johannes, 2011. "Modeling the long term health outcomes and cost-effectiveness of two interventions promoting fruit and vegetable intake among schoolchildren," Economics & Human Biology, Elsevier, vol. 9(1), pages 14-22, January.
  498. Erin M Stuckey & Jennifer Stevenson & Katya Galactionova & Amrish Y Baidjoe & Teun Bousema & Wycliffe Odongo & Simon Kariuki & Chris Drakeley & Thomas A Smith & Jonathan Cox & Nakul Chitnis, 2014. "Modeling the Cost Effectiveness of Malaria Control Interventions in the Highlands of Western Kenya," PLOS ONE, Public Library of Science, vol. 9(10), pages 1-11, October.
  499. Renata Leborato Guerra & Luciana Castaneda & Rita de Cássia Ribeiro Albuquerque & Camila Belo Tavares Ferreira & Flávia de Miranda Corrêa & Ricardo Ribeiro Alves Fernandes & Liz Maria Almeida, 2019. "Patient Preferences for Breast Cancer Treatment Interventions: A Systematic Review of Discrete Choice Experiments," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 12(6), pages 559-569, December.
  500. Brown, Vicki & Diomedi, Belen Zapata & Moodie, Marj & Veerman, J. Lennert & Carter, Rob, 2016. "A systematic review of economic analyses of active transport interventions that include physical activity benefits," Transport Policy, Elsevier, vol. 45(C), pages 190-208.
  501. J. Banefelt & S. Hallberg & K. M. Fox & J. Mesterton & C. J. Paoli & G. Johansson & L.-Å. Levin & P. Sobocki & S. R. Gandra, 2016. "Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(9), pages 1117-1124, December.
  502. Nikita M. John & Stuart J. Wright & Sean P. Gavan & Caroline M. Vass, 2019. "The role of information provision in economic evaluations of non-invasive prenatal testing: a systematic review," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(8), pages 1123-1131, November.
  503. Anthony Newall & Mark Jit & Philippe Beutels, 2012. "Economic Evaluations of Childhood Influenza Vaccination," PharmacoEconomics, Springer, vol. 30(8), pages 647-660, August.
  504. Giuseppe Turchetti & S. Bellelli & M. Amato & S. Bianchi & P. Conti & A. Cupisti & V. Panichi & A. Rosati & F. Pizzarelli, 2017. "The social cost of chronic kidney disease in Italy," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(7), pages 847-858, September.
  505. Morton, Alec & Thomas, Ranjeeta & Smith, Peter C., 2016. "Decision rules for allocation of finances to health systems strengthening," Journal of Health Economics, Elsevier, vol. 49(C), pages 97-108.
  506. Klaus Eichler & Simon Wieser & Urs Brügger, 2009. "The costs of limited health literacy: a systematic review," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 54(5), pages 313-324, October.
  507. Nadia Yakhelef & Martine Audibert & Bruno Peirera & Antoine Mons & Emmanuel Chabert, 2015. "Cost-utility Analysis of Vertebroplasty versus Thoracolumbosacral Orthosis in the Treatment of Traumatic Vertebral Fractures," CERDI Working papers halshs-01241824, HAL.
  508. David Parkin & Nancy Devlin, 2007. "‘Is there a case for using visual analogue scale valuations in CUA? Yes there is a case, but what does it add to ordinal data?’ a rejoinder," Health Economics, John Wiley & Sons, Ltd., vol. 16(6), pages 649-651, June.
  509. Bernard van den Berg & Amiram Gafni & France Portrait, 2013. "Attributing a monetary value to patients’ time: A contingent valuation approach," Working Papers 090cherp, Centre for Health Economics, University of York.
  510. Meryl Darlington & Pascal Gueret & Jean-Pierre Laissy & Antoine Pierucci & Hassani Maoulida & Céline Quelen & Ralph Niarra & Gilles Chatellier & Isabelle Durand-Zaleski, 2015. "Cost-effectiveness of computed tomography coronary angiography versus conventional invasive coronary angiography," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(6), pages 647-655, July.
  511. Lisa Boden & Ian Handel & Neil Hawkins & Fiona Houston & Helen Fryer & Rowland Kao, 2012. "An Economic Evaluation of Preclinical Testing Strategies Compared to the Compulsory Scrapie Flock Scheme in the Control of Classical Scrapie," PLOS ONE, Public Library of Science, vol. 7(3), pages 1-8, March.
  512. Bo Hu & Alex Z. Fu, 2010. "Predicting Utility for Joint Health States: A General Framework and a New Nonparametric Estimator," Medical Decision Making, , vol. 30(5), pages 29-39, September.
  513. Christabel C Enweronu-Laryea & Hilary D Andoh & Audrey Frimpong-Barfi & Francis M Asenso-Boadi, 2018. "Parental costs for in-patient neonatal services for perinatal asphyxia and low birth weight in Ghana," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-14, October.
  514. Deborah A. Marshall & F. Reed Johnson & Nathalie A. Kulin & Semra Özdemir & Judith M. E. Walsh & John K. Marshall & Stephanie Van Bebber & Kathryn A. Phillips, 2009. "How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated‐choice survey," Health Economics, John Wiley & Sons, Ltd., vol. 18(12), pages 1420-1439, December.
  515. Julien Forder & Katerina Gousia & Eirini-Christina Saloniki, 2019. "The impact of long-term care on primary care doctor consultations for people over 75 years," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 375-387, April.
  516. McCarthy, Ian M., 2016. "Eliminating composite bias in treatment effects estimates: Applications to quality of life assessment," Journal of Health Economics, Elsevier, vol. 50(C), pages 47-58.
  517. Tarik Benmarhnia & Pierre-Alexandre Dionne & Éric Tchouaket & Alvine K. Fansi & Astrid Brousselle, 2017. "Investing in a healthy lifestyle strategy: is it worth it?," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 62(1), pages 3-13, January.
  518. Beate Jahn & Sarah Friedrich & Joachim Behnke & Joachim Engel & Ursula Garczarek & Ralf Münnich & Markus Pauly & Adalbert Wilhelm & Olaf Wolkenhauer & Markus Zwick & Uwe Siebert & Tim Friede, 2022. "On the role of data, statistics and decisions in a pandemic," AStA Advances in Statistical Analysis, Springer;German Statistical Society, vol. 106(3), pages 349-382, September.
  519. Ulla K. Griffiths & Benedict Anigbogu & Kiran Nanchahal, 2012. "Economic evaluations of adult weight management interventions," Applied Health Economics and Health Policy, Springer, vol. 10(3), pages 145-162, May.
  520. Dominic Trépel, 2011. "Informal Cost of Dementia Care – A Proxy-Good Valuation in Ireland," The Economic and Social Review, Economic and Social Studies, vol. 42(4), pages 479-503.
  521. Matthew Franklin & Sarah Davis & Michelle Horspool & Wei Sun Kua & Steven Julious, 2017. "Economic Evaluations Alongside Efficient Study Designs Using Large Observational Datasets: the PLEASANT Trial Case Study," PharmacoEconomics, Springer, vol. 35(5), pages 561-573, May.
  522. Mansdotter, Anna & Lindholm, Lars & Winkvist, Anna, 2007. "Paternity leave in Sweden--Costs, savings and health gains," Health Policy, Elsevier, vol. 82(1), pages 102-115, June.
  523. Paul Tappenden & James Chilcott, 2014. "Avoiding and Identifying Errors and Other Threats to the Credibility of Health Economic Models," PharmacoEconomics, Springer, vol. 32(10), pages 967-979, October.
  524. Astrid Ledgaard Holm & Lennert Veerman & Linda Cobiac & Ola Ekholm & Finn Diderichsen, 2014. "Cost-Effectiveness of Preventive Interventions to Reduce Alcohol Consumption in Denmark," PLOS ONE, Public Library of Science, vol. 9(2), pages 1-9, February.
  525. Maximilian Hatz & Katharina Schremser & Wolf Rogowski, 2014. "Is Individualized Medicine More Cost-Effective? A Systematic Review," PharmacoEconomics, Springer, vol. 32(5), pages 443-455, May.
  526. Julien Forder, 2009. "Long‐term care and hospital utilisation by older people: an analysis of substitution rates," Health Economics, John Wiley & Sons, Ltd., vol. 18(11), pages 1322-1338, November.
  527. Emma McIntosh, 2006. "Using Discrete Choice Experiments within a Cost-Benefit Analysis Framework," PharmacoEconomics, Springer, vol. 24(9), pages 855-868, September.
  528. Michael Iskedjian & Barbara Jaszewski & Olivier Desjardins, 2011. "Comparison of Scores Derived from the Box Score-11 Scale and the Pain Attribute of the Health Utilities Index-3," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 4(4), pages 259-265, December.
  529. Sheena Arora & Stephen Goodall & Rosalie Viney & Stewart Einfeld, 2019. "Using Discrete-Choice Experiment Methods to Estimate the Value of Informal Care: The Case of Children with Intellectual Disability," PharmacoEconomics, Springer, vol. 37(4), pages 501-511, April.
  530. Jeff Richardson & Angelo Iezzi & Gang Chen & Aimee Maxwell, 2017. "Communal Sharing and the Provision of Low-Volume High-Cost Health Services: Results of a Survey," PharmacoEconomics - Open, Springer, vol. 1(1), pages 13-23, March.
  531. de Bruin, Simone R. & Heijink, Richard & Lemmens, Lidwien C. & Struijs, Jeroen N. & Baan, Caroline A., 2011. "Impact of disease management programs on healthcare expenditures for patients with diabetes, depression, heart failure or chronic obstructive pulmonary disease: A systematic review of the literature," Health Policy, Elsevier, vol. 101(2), pages 105-121, July.
  532. Ana Lucia Andrade & Eliane T Afonso & Ruth Minamisava & Ana Luiza Bierrenbach & Elier B Cristo & Otaliba L Morais-Neto & Gabriela M Policena & Carla M A S Domingues & Cristiana M Toscano, 2017. "Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: A time-series analysis," PLOS ONE, Public Library of Science, vol. 12(9), pages 1-19, September.
  533. Naomi Lince-Deroche & Craig van Rensburg & Jaqueline Roseleur & Busola Sanusi & Jane Phiri & Pam Michelow & Jennifer S Smith & Cindy Firnhaber, 2018. "Costs and cost-effectiveness of LEEP versus cryotherapy for treating cervical dysplasia among HIV-positive women in Johannesburg, South Africa," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-13, October.
  534. Sun Sun & Nan Luo & Erik Stenberg & Lars Lindholm & Klas-Göran Sahlén & Karl A. Franklin & Yang Cao, 2022. "Sequential Multiple Imputation for Real-World Health-Related Quality of Life Missing Data after Bariatric Surgery," IJERPH, MDPI, vol. 19(17), pages 1-16, August.
  535. Alfredo Palacios & Carlos Rojas-Roque & Lucas González & Ariel Bardach & Agustín Ciapponi & Claudia Peckaitis & Andres Pichon-Riviere & Federico Augustovski, 2021. "Direct Medical Costs, Productivity Loss Costs and Out-Of-Pocket Expenditures in Women with Breast Cancer in Latin America and the Caribbean: A Systematic Review," PharmacoEconomics, Springer, vol. 39(5), pages 485-502, May.
  536. Dominik J. Wettstein & Stefan Boes, 2019. "Effectiveness of National Pricing Policies for Patent-Protected Pharmaceuticals in the OECD: A Systematic Literature Review," Applied Health Economics and Health Policy, Springer, vol. 17(2), pages 143-162, April.
  537. Kittiphong Thiboonboon & Wantanee Kulpeng & Yot Teerawattananon, 2018. "An economic analysis of chromosome testing in couples with children who have structural chromosome abnormalities," PLOS ONE, Public Library of Science, vol. 13(6), pages 1-14, June.
  538. Hans-Helmut König & Oliver Günther & Matthias Angermeyer & Christiane Roick, 2009. "Utility Assessment in Patients with Mental Disorders," PharmacoEconomics, Springer, vol. 27(5), pages 405-419, May.
  539. Alastair Canaway & Hareth Al-Janabi & Philip Kinghorn & Cara Bailey & Joanna Coast, 2019. "Close-Person Spill-Overs in End-of-Life Care: Using Hierarchical Mapping to Identify Whose Outcomes to Include in Economic Evaluations," PharmacoEconomics, Springer, vol. 37(4), pages 573-583, April.
  540. Hoch, Jeffrey S. & Blume, Jeffrey D., 2008. "Measuring and illustrating statistical evidence in a cost-effectiveness analysis," Journal of Health Economics, Elsevier, vol. 27(2), pages 476-495, March.
  541. Samer A. Kharroubi & Yara Beyh, 2021. "Bayesian modeling of health state preferences: could borrowing strength from existing countries’ valuations produce better estimates," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(5), pages 773-788, July.
  542. Edward Wilson & Erika Sims & Stanley Musgrave & Lee Shepstone & Annie Blyth & Jamie Murdoch & H. Mugford & Elizabeth Juniper & Jon Ayres & Stephanie Wolfe & Daryl Freeman & Richard Gilbert & Ian Harve, 2010. "Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy," PharmacoEconomics, Springer, vol. 28(7), pages 585-595, July.
  543. S. Rajsic & H. Gothe & H. H. Borba & G. Sroczynski & J. Vujicic & T. Toell & Uwe Siebert, 2019. "Economic burden of stroke: a systematic review on post-stroke care," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(1), pages 107-134, February.
  544. Sera Thomas & William Hodge & Monali Malvankar-Mehta, 2015. "The Cost-Effectiveness Analysis of Teleglaucoma Screening Device," PLOS ONE, Public Library of Science, vol. 10(9), pages 1-12, September.
  545. Eduard Beck & Carlos Avila & Sofia Gerbase & Guy Harling & Paul Lay, 2012. "Counting the Cost of Not Costing HIV Health Facilities Accurately," PharmacoEconomics, Springer, vol. 30(10), pages 887-902, October.
  546. Kobelt, G., 2013. "Health Economics: An Introduction to Economic Evaluation," Monographs, Office of Health Economics, number 000004.
  547. Shelley Potter & Charlotte Davies & Gareth Davies & Caoimhe Rice & William Hollingworth, 2020. "The use of micro-costing in economic analyses of surgical interventions: a systematic review," Health Economics Review, Springer, vol. 10(1), pages 1-11, December.
  548. William Green & John Hutton, 2014. "Health technology assessments in England: an analysis of the NICE Medical Technologies Evaluation Programme," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(5), pages 449-452, June.
  549. Tewodaj Mengistu & Andrés Berruti & Anna Krivelyova & Meghan Swor & Rachel Waite & Godson Maro, 2019. "Cost of providing emergency obstetric care in Tanzania's Kigoma region," International Journal of Health Planning and Management, Wiley Blackwell, vol. 34(4), pages 1510-1519, October.
  550. Karl Claxton & Mike Paulden & Hugh Gravelle & Werner Brouwer & Anthony J. Culyer, 2011. "Discounting and decision making in the economic evaluation of health‐care technologies," Health Economics, John Wiley & Sons, Ltd., vol. 20(1), pages 2-15, January.
  551. Mitchell, Paul Mark & Roberts, Tracy E. & Barton, Pelham M. & Coast, Joanna, 2015. "Assessing sufficient capability: A new approach to economic evaluation," Social Science & Medicine, Elsevier, vol. 139(C), pages 71-79.
  552. Marc-André Blanchette & Mette Jensen Stochkendahl & Roxane Borges Da Silva & Jill Boruff & Pamela Harrison & André Bussières, 2016. "Effectiveness and Economic Evaluation of Chiropractic Care for the Treatment of Low Back Pain: A Systematic Review of Pragmatic Studies," PLOS ONE, Public Library of Science, vol. 11(8), pages 1-25, August.
  553. Richard Grieve & Richard Nixon & Simon G. Thompson, 2010. "Bayesian Hierarchical Models for Cost-Effectiveness Analyses that Use Data from Cluster Randomized Trials," Medical Decision Making, , vol. 30(2), pages 163-175, March.
  554. Sandjar Djalalov & Linda Rabeneck & George Tomlinson & Karen E. Bremner & Robert Hilsden & Jeffrey S. Hoch, 2014. "A Review and Meta-analysis of Colorectal Cancer Utilities," Medical Decision Making, , vol. 34(6), pages 809-818, August.
  555. Barbara Graaff & Amanda Neil & Kristy Sanderson & Lei Si & Kwang Yee & Andrew Palmer, 2015. "A Systematic Review and Narrative Synthesis of Health Economic Studies Conducted for Hereditary Haemochromatosis," Applied Health Economics and Health Policy, Springer, vol. 13(5), pages 469-483, October.
  556. Eckermann, Simon & Coelli, Tim, 2013. "Including quality attributes in efficiency measures consistent with net benefit: Creating incentives for evidence based medicine in practice," Social Science & Medicine, Elsevier, vol. 76(C), pages 159-168.
  557. Jelena Stevanović & Petros Pechlivanoglou & Marthe A Kampinga & Paul F M Krabbe & Maarten J Postma, 2016. "Multivariate Meta-Analysis of Preference-Based Quality of Life Values in Coronary Heart Disease," PLOS ONE, Public Library of Science, vol. 11(3), pages 1-20, March.
  558. Colin Green & David A Richards & Jacqueline J Hill & Linda Gask & Karina Lovell & Carolyn Chew-Graham & Peter Bower & John Cape & Stephen Pilling & Ricardo Araya & David Kessler & J Martin Bland & Sim, 2014. "Cost-Effectiveness of Collaborative Care for Depression in UK Primary Care: Economic Evaluation of a Randomised Controlled Trial (CADET)," PLOS ONE, Public Library of Science, vol. 9(8), pages 1-12, August.
  559. Jonathon Campbell & Thenuga Sasitharan & Fawziah Marra, 2015. "A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis Infection," Applied Health Economics and Health Policy, Springer, vol. 13(4), pages 325-340, August.
  560. Nadia Yakhelef & Martine Audibert & Gabriella Ferlazzo & Joseph Sitienei & Steve Wanjala & Francis Varaine & Maryline Bonnet & Helena Huerga, 2020. "Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis," Post-Print halshs-03170014, HAL.
  561. Indrani Gupta & Mayur Trivedi, 2014. "Willingness to Pay for Health Insurance Among HIV-Positive Patients in India," Applied Health Economics and Health Policy, Springer, vol. 12(6), pages 601-610, December.
  562. Buckingham, K. & Devlin, N., 2008. "A note on the nature of utility in time and health and implications for cost utility analysis," Working Papers 08/02, Department of Economics, City University London.
  563. Yasuhiro Hagiwara & Takeru Shiroiwa & Kojiro Shimozuma & Takuya Kawahara & Yukari Uemura & Takanori Watanabe & Naruto Taira & Takashi Fukuda & Yasuo Ohashi & Hirofumi Mukai, 2018. "Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study," PharmacoEconomics, Springer, vol. 36(2), pages 215-223, February.
  564. Valentina Tonei, 2017. "Mother’s health after childbirth: does delivery method matter?," Discussion Papers 17/11, Department of Economics, University of York.
  565. Jaithri Ananthapavan & Gary Sacks & Marj Moodie & Rob Carter, 2014. "Economics of Obesity — Learning from the Past to Contribute to a Better Future," IJERPH, MDPI, vol. 11(4), pages 1-19, April.
  566. Banke-Thomas, Aduragbemi & Nieuwenhuis, Sonja & Ologun, Adesoji & Mortimore, Gordon & Mpakateni, Martin, 2019. "Embedding value-for-money in practice: A case study of a health pooled fund programme implemented in conflict-affected South Sudan," Evaluation and Program Planning, Elsevier, vol. 77(C).
  567. Semra Özdemir & F. Reed Johnson, 2013. "Estimating willingness to pay: do health and environmental researchers have different methodological standards?," Applied Economics, Taylor & Francis Journals, vol. 45(16), pages 2215-2229, June.
  568. Perraudin, Clémence & Bugnon, Olivier & Pelletier-Fleury, Nathalie, 2016. "Expanding professional pharmacy services in European community setting: Is it cost-effective? A systematic review for health policy considerations," Health Policy, Elsevier, vol. 120(12), pages 1350-1362.
  569. George Dranitsaris & George Papadopoulos, 2015. "Health Technology Assessment of Cancer Drugs in Canada, the United Kingdom and Australia: Should the United States Take Notice?," Applied Health Economics and Health Policy, Springer, vol. 13(3), pages 291-302, June.
  570. Hareth Al-Janabi & Nikki McCaffrey & Julie Ratcliffe, 2013. "Carer Preferences in Economic Evaluation and Healthcare Decision Making," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 6(4), pages 235-239, December.
  571. Ana C. Montesinos Gálvez & Francisco Jódar Sánchez & Carmen Alcántara Moreno & Antonio J. Pérez Fernández & Rosario Benítez García & Mercedes Coca López & María Paz Bienvenido Ramírez & Monserrat Cabr, 2020. "Value-Based Healthcare in Ostomies," IJERPH, MDPI, vol. 17(16), pages 1-15, August.
  572. Hendramoorthy Maheswaran & Stavros Petrou & Danielle Cohen & Peter MacPherson & Felistas Kumwenda & David G Lalloo & Elizabeth L Corbett & Aileen Clarke, 2018. "Economic costs and health-related quality of life outcomes of hospitalised patients with high HIV prevalence: A prospective hospital cohort study in Malawi," PLOS ONE, Public Library of Science, vol. 13(3), pages 1-21, March.
  573. J.- Graf v. d. Schulenburg & Christoph Vauth & Thomas Mittendorf & Wolfgang Greiner, 2007. "Methods for determining cost-benefit ratios for pharmaceuticals in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 8(1), pages 5-31, September.
  574. Douwe Postmus & Tommi Tervonen & Gert Valkenhoef & Hans Hillege & Erik Buskens, 2014. "A multi-criteria decision analysis perspective on the health economic evaluation of medical interventions," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(7), pages 709-716, September.
  575. Emily Lancsar & Jordan Louviere, 2008. "Conducting Discrete Choice Experiments to Inform Healthcare Decision Making," PharmacoEconomics, Springer, vol. 26(8), pages 661-677, August.
  576. Blake J Angell & Janani Muhunthan & Michelle Irving & Sandra Eades & Stephen Jan, 2014. "Global Systematic Review of the Cost-Effectiveness of Indigenous Health Interventions," PLOS ONE, Public Library of Science, vol. 9(11), pages 1-12, November.
  577. Laurent Coudeville & Annelies Van Rie & Denis Getsios & J Jaime Caro & Pascal Crépey & Van Hung Nguyen, 2009. "Adult Vaccination Strategies for the Control of Pertussis in the United States: An Economic Evaluation Including the Dynamic Population Effects," PLOS ONE, Public Library of Science, vol. 4(7), pages 1-9, July.
  578. Robberstad, Bjarne & Norheim, Ole F., 2011. "Incorporating concerns for equal lifetime health in evaluations of public health programs," Social Science & Medicine, Elsevier, vol. 72(10), pages 1711-1716, May.
  579. Yira Natalia Alfonso & Olakunle Alonge & Dewan Md Emdadul Hoque & Md Kamran Ul Baset & Adnan A. Hyder & David Bishai, 2017. "Care-Seeking Patterns and Direct Economic Burden of Injuries in Bangladesh," IJERPH, MDPI, vol. 14(5), pages 1-9, April.
  580. Krol, Marieke & Brouwer, Werner B.F. & Severens, Johan L. & Kaper, Janneke & Evers, Silvia M.A.A., 2012. "Productivity cost calculations in health economic evaluations: Correcting for compensation mechanisms and multiplier effects," Social Science & Medicine, Elsevier, vol. 75(11), pages 1981-1988.
  581. Dan Greenberg & Joseph S. Pliskin, 2006. "Using Health State Classification Systems for Utility Elicitation in the Elderly," Medical Decision Making, , vol. 26(3), pages 220-222, May.
  582. Jacinto Nogueira & Eva Rodríguez-Míguez, 2015. "Using the SF-6D to measure the impact of alcohol dependence on health-related quality of life," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(4), pages 347-356, May.
  583. Maureen Rutten-van Mölken & Lucas Goossens, 2012. "Cost Effectiveness of Pharmacological Maintenance Treatment for Chronic Obstructive Pulmonary Disease," PharmacoEconomics, Springer, vol. 30(4), pages 271-302, April.
  584. Adang, Eddy M.M. & Wensing, Michel, 2008. "Economic barriers to implementation of innovations in health care: Is the long run-short run efficiency discrepancy a paradox?," Health Policy, Elsevier, vol. 88(2-3), pages 236-242, December.
  585. Elizabeth-Ann Schroeder & Stavros Petrou & Gail Balfour & Oya Edamma & Paul Heath, 2009. "The economic costs of Group B Streptococcus (GBS) disease: prospective cohort study of infants with GBS disease in England," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(3), pages 275-285, July.
  586. Christian Brettschneider & Sebastian Kohlmann & Benjamin Gierk & Bernd Löwe & Hans-Helmut König, 2017. "Depression screening with patient-targeted feedback in cardiology: The cost-effectiveness of DEPSCREEN-INFO," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-15, August.
  587. Diana M. Negoescu & Kostas Bimpikis & Margaret L. Brandeau & Dan A. Iancu, 2018. "Dynamic Learning of Patient Response Types: An Application to Treating Chronic Diseases," Management Science, INFORMS, vol. 64(8), pages 3469-3488, August.
  588. John Brazier & Carolyn Czoski-Murray & Jennifer Roberts & Martin Brown & Tara Symonds & Con Kelleher, 2008. "Estimation of a Preference-Based Index from a Condition-Specific Measure: The King's Health Questionnaire," Medical Decision Making, , vol. 28(1), pages 113-126, January.
  589. Turner, Alex J. & Fichera, Eleonora & Sutton, Matt, 2022. "Estimating the late-life effects of social and emotional skills in childhood using midlife mediators," Social Science & Medicine, Elsevier, vol. 292(C).
  590. Margreet Franken & Fredrik Nilsson & Frank Sandmann & Anthonius Boer & Marc Koopmanschap, 2013. "Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making," PharmacoEconomics, Springer, vol. 31(9), pages 781-797, September.
  591. Heckley, Gawain & Gerdtham, Ulf-G. & Kjellsson, Gustav, 2016. "A general method for decomposing the causes of socioeconomic inequality in health," Journal of Health Economics, Elsevier, vol. 48(C), pages 89-106.
  592. Samira B. Jabakhanji & Jan Sorensen & Gintare Valentelyte & Lee Ann Burke & Brendan McElroy & Aileen Murphy, 2021. "Assessing direct healthcare costs when restricted to self-reported data: a scoping review," Health Economics Review, Springer, vol. 11(1), pages 1-15, December.
  593. Henderson, Catherine & Knapp, Martin & Fernández, José-Luis & Beecham, Jennifer & Hirani, Shashivadan P. & Beynon, Michelle & Cartwright, Martin & Rixon, Lorna & Doll, Helen & Bower, Peter & Steventon, 2014. "Cost-effectiveness of telecare for people with social care needs: the Whole Systems Demonstrator cluster randomised trial," LSE Research Online Documents on Economics 57270, London School of Economics and Political Science, LSE Library.
  594. McDaid, David & Park, A-La, 2011. "Investing in mental health and well-being: findingsfrom the DataPrev project," LSE Research Online Documents on Economics 39875, London School of Economics and Political Science, LSE Library.
  595. Dukhanin, Vadim & Searle, Alexandra & Zwerling, Alice & Dowdy, David W. & Taylor, Holly A. & Merritt, Maria W., 2018. "Integrating social justice concerns into economic evaluation for healthcare and public health: A systematic review," Social Science & Medicine, Elsevier, vol. 198(C), pages 27-35.
  596. Dirk Steijger & Chandrima Chatterjee & Wim Groot & Milena Pavlova, 2022. "Challenges and Limitations in Distributional Cost-Effectiveness Analysis: A Systematic Literature Review," IJERPH, MDPI, vol. 20(1), pages 1-14, December.
  597. Aki Tsuchiya & Paul Dolan, 2009. "Equality of what in health? Distinguishing between outcome egalitarianism and gain egalitarianism," Health Economics, John Wiley & Sons, Ltd., vol. 18(2), pages 147-159, February.
  598. Benjamin P Linas & Devra M Barter & Jared A Leff & Sabrina A Assoumou & Joshua A Salomon & Milton C Weinstein & Arthur Y Kim & Bruce R Schackman, 2014. "The Hepatitis C Cascade of Care: Identifying Priorities to Improve Clinical Outcomes," PLOS ONE, Public Library of Science, vol. 9(5), pages 1-11, May.
  599. Eddy Adang, 2008. "Economic evaluation of innovative technologies in health care should include a short-run perspective," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 9(4), pages 381-384, November.
  600. Christopher McCabe & Richard Edlin & Peter Hall, 2013. "Navigating Time and Uncertainty in Health Technology Appraisal: Would a Map Help?," PharmacoEconomics, Springer, vol. 31(9), pages 731-737, September.
  601. James D. Chambers & Peter J. Neumann & Martin J. Buxton, 2010. "Does Medicare Have an Implicit Cost-Effectiveness Threshold?," Medical Decision Making, , vol. 30(4), pages 14-27, July.
  602. Ângela Jornada Ben & Johanna M. Dongen & Mohamed El Alili & Martijn W. Heymans & Jos W. R. Twisk & Janet L. MacNeil-Vroomen & Maartje Wit & Susan E. M. Dijk & Teddy Oosterhuis & Judith E. Bosmans, 2023. "The handling of missing data in trial-based economic evaluations: should data be multiply imputed prior to longitudinal linear mixed-model analyses?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(6), pages 951-965, August.
  603. Laura Burgers & William Redekop & Johan Severens, 2014. "Challenges in Modelling the Cost Effectiveness of Various Interventions for Cardiovascular Disease," PharmacoEconomics, Springer, vol. 32(7), pages 627-637, July.
  604. Federico Augustovski & Cynthia Iglesias & Andrea Manca & Michael Drummond & Adolfo Rubinstein & Sebastián Martií, 2009. "Barriers to Generalizability of Health Economic Evaluations in Latin America and the Caribbean Region," PharmacoEconomics, Springer, vol. 27(11), pages 919-929, November.
  605. Michael Urbich & Gary Globe & Krystallia Pantiri & Marieke Heisen & Craig Bennison & Heidi S. Wirtz & Gian Luca Di Tanna, 2020. "A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014–2020)," PharmacoEconomics, Springer, vol. 38(11), pages 1219-1236, November.
  606. Halvard Angelsen & Jan Norum & Villy Angelsen & Fred Mürer & Randi Erlandsen, 2017. "A Model-Based Cost-Minimization Analysis as a Decision Tool in Obstetric Care in Helgeland, Northern Norway," Global Journal of Health Science, Canadian Center of Science and Education, vol. 9(1), pages 191-191, January.
  607. Morton, Alec, 2014. "Aversion to health inequalities in healthcare prioritisation: A multicriteria optimisation perspective," Journal of Health Economics, Elsevier, vol. 36(C), pages 164-173.
  608. Andrea Klonschinski, 2021. "Universal Metrics for Climate Change Adaptation Finance? A Cautionary Tale," Sustainability, MDPI, vol. 13(16), pages 1-14, August.
  609. Stuart J. Wright & Mike Paulden & Katherine Payne, 2020. "Implementing Interventions with Varying Marginal Cost-Effectiveness: An Application in Precision Medicine," Medical Decision Making, , vol. 40(7), pages 924-938, October.
  610. Christine Mpundu-Kaambwa & Gang Chen & Remo Russo & Katherine Stevens & Karin Dam Petersen & Julie Ratcliffe, 2017. "Mapping CHU9D Utility Scores from the PedsQLTM 4.0 SF-15," PharmacoEconomics, Springer, vol. 35(4), pages 453-467, April.
  611. Anthony J. Culyer, 2012. "Hic Sunt Dracones," Medical Decision Making, , vol. 32(1), pages 25-32, January.
  612. Wren, Maev-Ann & Gillespie, Paddy & Smith, Samantha & Kearns, Karen & Crichton,Siobhan & Parkin, David & Hickey, Anne & Horgan, Frances & Wiley, Miriam, 2014. "Towards Earlier Discharge, Better Outcomes, Lower Cost: Stroke Rehabilitation in Ireland," Research Series, Economic and Social Research Institute (ESRI), number BKMNEXT277, June.
  613. Jane Hall & Patricia Kenny & Ishrat Hossain & Deborah J. Street & Stephanie A. Knox, 2014. "Providing Informal Care in Terminal Illness," Medical Decision Making, , vol. 34(6), pages 731-745, August.
  614. Shah, Koonal K., 2009. "Severity of illness and priority setting in healthcare: A review of the literature," Health Policy, Elsevier, vol. 93(2-3), pages 77-84, December.
  615. Chen-Wei Pan & Hong-Peng Sun & Hui-Jun Zhou & Qinghua Ma & Yong Xu & Nan Luo & Pei Wang, 2016. "Valuing Health-Related Quality of Life in Type 2 Diabetes Patients in China," Medical Decision Making, , vol. 36(2), pages 234-241, February.
  616. Paul Gavaza & Karen Rascati & Abiola Oladapo & Star Khoza, 2010. "The State of Health Economic Evaluation Research in Nigeria," PharmacoEconomics, Springer, vol. 28(7), pages 539-553, July.
  617. Maximilian Hatz & Reiner Leidl & Nichola Yates & Björn Stollenwerk, 2014. "A Systematic Review of the Quality of Economic Models Comparing Thrombosis Inhibitors in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention," PharmacoEconomics, Springer, vol. 32(4), pages 377-393, April.
  618. Yumi Asukai & Michael Baldwin & Tiago Fonseca & Alastair Gray & Laura Mungapen & David Price, 2013. "Improving Clinical Reality in Chronic Obstructive Pulmonary Disease Economic Modelling," PharmacoEconomics, Springer, vol. 31(2), pages 151-161, February.
  619. Lena Sannemann & Lisa Bach & Kira Isabel Hower & Peter Ihle & Kai Keller & Charlotte Leikert & Christin Leminski & Adriana Meixner & Ingo Meyer & Laura Nordmeyer & Samia Peltzer & Sophie Peter & Belin, 2023. "Effects of a Primary Care-Based Intervention on the Identification and Management of Patients with Coronary Heart Disease and Mental or Cognitive Comorbidity—A Study Protocol," IJERPH, MDPI, vol. 20(10), pages 1-13, May.
  620. Rob Anderson, 2010. "Systematic reviews of economic evaluations: utility or futility?," Health Economics, John Wiley & Sons, Ltd., vol. 19(3), pages 350-364, March.
  621. Pickles, Kristen & Lancsar, Emily & Seymour, Janelle & Parkin, David & Donaldson, Cam & Carter, Stacy M., 2019. "Accounts from developers of generic health state utility instruments explain why they produce different QALYs: A qualitative study," Social Science & Medicine, Elsevier, vol. 240(C).
  622. Miqdad Asaria & Susan Griffin & Richard Cookson & Sophie Whyte & Paul Tappenden, 2015. "Distributional Cost‐Effectiveness Analysis of Health Care Programmes – A Methodological Case Study of the UK Bowel Cancer Screening Programme," Health Economics, John Wiley & Sons, Ltd., vol. 24(6), pages 742-754, June.
  623. Fan Yang & Colin Angus & Ana Duarte & Duncan Gillespie & Simon Walker & Susan Griffin, 2020. "Impact of Socioeconomic Differences on Distributional Cost-effectiveness Analysis," Medical Decision Making, , vol. 40(5), pages 606-618, July.
  624. Klazien Matter-Walstra & Dirk Klingbiel & Thomas Szucs & Bernhard Pestalozzi & Matthias Schwenkglenks, 2014. "Using the EuroQol EQ-5D in Swiss Cancer Patients, Which Value Set Should be Applied?," PharmacoEconomics, Springer, vol. 32(6), pages 591-599, June.
  625. Sevan Dirmesropian & James G. Wood & C. Raina MacIntyre & Philippe Beutels & Anthony T. Newall, 2016. "Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and Challenges," PharmacoEconomics, Springer, vol. 34(8), pages 723-731, August.
  626. Arjun Bhadhuri & Sue Jowett & Kate Jolly & Hareth Al-Janabi, 2017. "A Comparison of the Validity and Responsiveness of the EQ-5D-5L and SF-6D for Measuring Health Spillovers: A Study of the Family Impact of Meningitis," Medical Decision Making, , vol. 37(8), pages 882-893, November.
  627. Stuart Wright & Cheryl Jones & Katherine Payne & Nimarta Dharni & Fiona Ulph, 2015. "The Role of Information Provision in Economic Evaluations of Newborn Bloodspot Screening: A Systematic Review," Applied Health Economics and Health Policy, Springer, vol. 13(6), pages 615-626, December.
  628. Marilys Victoire RAZAKAMANANA & Martine AUDIBERT & Tantely ANDRIANANTOANDRO & Aina HARIMANANA, 2017. "Impact and Efficiency of the Integration of Diagnosis and Treatment of Pneumonia in Malaria Community Case Management in Madagascar," Working Papers 201706, CERDI.
  629. Leticia García-Mochón & Zuzana Špacírová & Jaime Espín, 2022. "Costing methodologies in European economic evaluation guidelines: commonalities and divergences," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(6), pages 979-991, August.
  630. Shankar Prinja & Yashpaul Sharma & Jyoti Dixit & Shyam Kumar Singh Thingnam & Rajesh Kumar, 2019. "Cost of Treatment of Valvular Heart Disease at a Tertiary Hospital in North India: Policy Implications," PharmacoEconomics - Open, Springer, vol. 3(3), pages 391-402, September.
  631. Maurílio de Souza Cazarim & Leonardo Régis Leira Pereira, 2018. "Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in Brazil," PLOS ONE, Public Library of Science, vol. 13(3), pages 1-16, March.
  632. Fuhmei Wang & Jung-Der Wang & Yu-Xiu Huang, 2016. "Health expenditures spent for prevention, economic performance, and social welfare," Health Economics Review, Springer, vol. 6(1), pages 1-10, December.
  633. Angelis, Aris & Kanavos, Panos, 2016. "Value-based assessment of new medical technologies: towards a robust methodological framework for the application of multiple criteria decision analysis in the context of health technology assessment," LSE Research Online Documents on Economics 65148, London School of Economics and Political Science, LSE Library.
  634. Casey Quinn, 2005. "Generalisable regression methods for costeffectiveness using copulas," Health, Econometrics and Data Group (HEDG) Working Papers 05/13, HEDG, c/o Department of Economics, University of York.
  635. Edwin Oberjé & Reina Kinderen & Silvia Evers & Cees Woerkum & Marijn Bruin, 2013. "Cost Effectiveness of Medication Adherence-Enhancing Interventions: A Systematic Review of Trial-Based Economic Evaluations," PharmacoEconomics, Springer, vol. 31(12), pages 1155-1168, December.
  636. Kittiphong Thiboonboon & Benjarin Santatiwongchai & Varit Chantarastapornchit & Waranya Rattanavipapong & Yot Teerawattananon, 2016. "A Systematic Review of Economic Evaluation Methodologies Between Resource-Limited and Resource-Rich Countries: A Case of Rotavirus Vaccines," Applied Health Economics and Health Policy, Springer, vol. 14(6), pages 659-672, December.
  637. Stephanie Nicolian & Thibault Butel & Laetitia Gambotti & Manon Durand & Antoine Filipovic-Pierucci & Alain Mallet & Mamadou Kone & Isabelle Durand-Zaleski & Marc Dommergues, 2019. "Cost-effectiveness of acupuncture versus standard care for pelvic and low back pain in pregnancy: A randomized controlled trial," PLOS ONE, Public Library of Science, vol. 14(4), pages 1-16, April.
  638. Marcelo Coca Perraillon & Ya-Chen Tina Shih & Ronald A. Thisted, 2015. "Predicting the EQ-5D-3L Preference Index from the SF-12 Health Survey in a National US Sample," Medical Decision Making, , vol. 35(7), pages 888-901, October.
  639. Susan F Rumisha & Janeth George & Veneranda M Bwana & Leonard E G Mboera, 2020. "Years of potential life lost and productivity costs due to premature mortality from six priority diseases in Tanzania, 2006-2015," PLOS ONE, Public Library of Science, vol. 15(6), pages 1-18, June.
  640. King, Julian, 2021. "Expanding theory-based evaluation: Incorporating value creation in a theory of change," Evaluation and Program Planning, Elsevier, vol. 89(C).
  641. Patrick W. Sullivan, 2011. "Are Utilities Bounded at 1.0? Implications for Statistical Analysis and Scale Development," Medical Decision Making, , vol. 31(6), pages 787-789, November.
  642. Pirhonen, Laura & Olofsson, Elisabeth Hansson & Fors, Andreas & Ekman, Inger & Bolin, Kristian, 2017. "Effects of person-centred care on health outcomes—A randomized controlled trial in patients with acute coronary syndrome," Health Policy, Elsevier, vol. 121(2), pages 169-179.
  643. Renske J. Hoefman & Job van Exel & John M. Rose & E. J. van de Wetering & Werner B. F. Brouwer, 2014. "A Discrete Choice Experiment to Obtain a Tariff for Valuing Informal Care Situations Measured with the CarerQol Instrument," Medical Decision Making, , vol. 34(1), pages 84-96, January.
  644. Laura Pirhonen & Hanna Gyllensten & Andreas Fors & Kristian Bolin, 2020. "Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(9), pages 1317-1327, December.
  645. Vivian Reckers-Droog & Maartje Goorden & Yifrah Kaminer & Lieke van Domburgh & Werner Brouwer & Leona Hakkaart-van Roijen, 2020. "Presentation and validation of the Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI): A preference-based measure for use in health-economic evaluations," PLOS ONE, Public Library of Science, vol. 15(9), pages 1-12, September.
  646. Billingsley Kaambwa & Norma B. Bulamu & Christine Mpundu-Kaambwa & Raymond Oppong, 2021. "Convergent and Discriminant Validity of the Barthel Index and the EQ-5D-3L When Used on Older People in a Rehabilitation Setting," IJERPH, MDPI, vol. 18(19), pages 1-16, September.
  647. Mathilda Bongers & Veerle Coupé & Elise Jansma & Egbert Smit & Carin Groot, 2012. "Cost Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer," PharmacoEconomics, Springer, vol. 30(1), pages 17-34, January.
  648. David Ceballos Hornero & Samuel Mongrut Montalván, 2021. "The Entrepreneurial Social Discount Rate: Risk Premium and Loss Aversion in New Ventures," Remef - Revista Mexicana de Economía y Finanzas Nueva Época REMEF (The Mexican Journal of Economics and Finance), Instituto Mexicano de Ejecutivos de Finanzas, IMEF, vol. 16(4), pages 1-24, Octubre -.
  649. Laurent Molinier & Hélène Bocquet & Vanina Bongard & Bernard Fraysse, 2009. "The economics of cochlear implant management in France: a multicentre analysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(3), pages 347-355, July.
  650. SeungJin Bae & Eun Bae & Sang Lim, 2014. "Sourcing Quality-of-Life Weights Obtained from Previous Studies: Theory and Reality in Korea," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 7(2), pages 141-150, June.
  651. Susmita Chatterjee & Anupam Sarkar & Krishna D Rao, 2016. "Using Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage – Do Costs Matter?," PLOS ONE, Public Library of Science, vol. 11(10), pages 1-8, October.
  652. Turgay Ayer & Can Zhang & Anthony Bonifonte & Anne C. Spaulding & Jagpreet Chhatwal, 2019. "Prioritizing Hepatitis C Treatment in U.S. Prisons," Operations Research, INFORMS, vol. 67(3), pages 853-873, May.
  653. Gijs Wetering & Willem Woertman & Andre Verbeek & Mireille Broeders & Eddy Adang, 2013. "Quantifying short run cost-effectiveness during a gradual implementation process," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(6), pages 911-918, December.
  654. Beth Woods & Paul Revill & Mark Sculpher & Karl Claxton, 2015. "Country-level cost-effectiveness thresholds: initial estimates and the need for further research," Working Papers 109cherp, Centre for Health Economics, University of York.
  655. Lisa Prosser & James Hammitt & Ron Keren, 2007. "Measuring Health Preferences for Use in Cost-Utility and Cost-Benefit Analyses of Interventions in Children," PharmacoEconomics, Springer, vol. 25(9), pages 713-726, September.
  656. Caroline Steigenberger & Magdalena Flatscher-Thoeni & Uwe Siebert & Andrea M. Leiter, 2022. "Determinants of willingness to pay for health services: a systematic review of contingent valuation studies," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(9), pages 1455-1482, December.
  657. Katia Noyes & Andrew W. Dick & Robert G. Holloway, 2007. "The Implications of Using US-Specific EQ-5D Preference Weights for Cost-Effectiveness Evaluation," Medical Decision Making, , vol. 27(3), pages 327-334, May.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.